Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, Bager F. 2001. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 45(7):2054–9.
Abdel-Wahab MF. 1982. Schistosomiasis in Egypt. Boca Raton, FL: CRC Press, Inc.
Acosta CJ, Galindo CM, Kimario J, Senkoro K, Urassa H, Casals C, Corachan M, Eseko N, Tanner M, Mshinda H, Lwilla F, Vila J, Alonso PL. 2001. Cholera outbreak in southern Tanzania: risk factors and patterns of transmission . Emerg Infect Dis 7(3 Suppl):583–7.
Adelman ZN, Blair CD, Carlson JO, Beaty BJ, Olson KE. 2001. Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol Biol 10(3):265–73.
Adeyi O, Hecht R, Njobvu E, Soucat A. 2001. AIDS, Poverty Reduction and Debt Relief: Toolkit for Mainstreaming HIV/AIDS Programmes into Development Instruments. UNAIDS/01.01E. Geneva: UNAIDS.
Afonso CL, Tulman ER, Lu Z, Balinsky CA, Moser BA, Becnel JJ, Rock DL, Kutish GF. 2001. Genome sequence of a baculovirus pathogenic for Culex nigripalpus. J Virol 75(22):11157–65.
Ahmad K. 2000. More deaths from Rift Valley fever in Saudi Arabia and Yemen. Lancet 356(9239):1422.
Alibek K. 1999. The Soviet Union’s anti-agricultural biological weapons. Ann N Y Acad Sci 894:18–9.
Alibek K., Handelman S. 2000. Biohazard. New York: Delta Books.
Alliance for the Prudent Use of Antibiotics (APUA). 2001. Antibiotic resistance: synthesis of recommendations by expert policy groups. WHO/CDS/CSR/DRS/2001.10. Geneva: WHO.
APUA. 2002. The Need to Improve Antimicrobial Use in Agriculture: Ecological and Human Health Consequences. Executive Summary. [Online]. Available: http://www.healthsci.tufts.edu/apua/Ecology/faairExecSum_6–02.html#ExSum [accessed June 13, 2002].
Almroth G, Ekermo B, Mansson AS, Svensson G, Widell A. 2002. Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long–term follow up (1989–January 1997). J Intern Med 251(2):119–28.
Alphey L, Beard CB, Billingsley P, Coetzee M, Crisanti A, Curtis C, Eggleston P, Godfray C, Hemingway J, Jacobs–Lorena M, James AA, Kafatos FC, Mukwaya LG, Paton M, Powell JR, Schneider W, Scott TW, Sina B, Sinden R, Sinkins S, Spielman A, Toure Y, Collins FH. 2002. Malaria control with genetically manipulated insect vectors. Science 298(5591):119–21.
Alterholt TB, LeChevalier MW, Norton WD, Rosen JS. 1998. Effect of rainfall on giardia and crypto. J Am Water Works Assoc 90:66–80.
American Social Health Association. 1998. Sexually Transmitted Disease in America: How Many Cases and at What Cost? Menlo Park, CA: Kaiser Family Foundation.
American Social Health Association. 2001. HPV Background Information. [Online]. Available: http://www.ashastd.org/hpvccrc/background.html [accessed March 5, 2003].
Animal and Plant Health Inspection Service (APHIS). 1992. The Foreign Animal Disease Diagnostic Laboratory at Plum Island Animal Disease Center. [Online]. Available: http://www.aphis.usda.gov/oa/pubs/fsfadlab.html [accessed January 29, 2003].
APHIS. 1999a. Poultry and Eggs. Washington, DC: U.S. Department of Agriculture.
APHIS. 1999b. Factsheet: Invasive Species. Washington, DC: U.S. Department of Agriculture.
APHIS. 2002. Chronic Wasting Disease. [Online]. Available: http://www.aphis.usda.gov/lpa/issues/cwd/cwd.html [accessed February 22, 2003].
Aoki T. 1988. Drug-resistant plasmids from fish pathogens. Microbiol Sci 5(7):219–23.
Aral S. 1999. Elimination and reintroduction of a sexually transmitted disease: lessons to be learned? Am J Public Health 89(7):995–7.
Armstrong GL, Conn LA, Pinner RW. 1999. Trends in infectious disease mortality in the United States during the 20th century. JAMA 281(1):61–6.
Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O’Toole T, Parker G, et al. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285(8):1059–70.
Asthana S, Oostvogels R. 1996. Community participation in HIV prevention: problems and prospects for community-based strategies among female sex workers in Madras. Soc Sci Med 43(2):133–48.
Attaran A, Roberts DR, Curtis CF, Kilama WL. 2000. Balancing risks on the backs of the poor . Nat Med 6(7):729–31.
Baier EG. 1997. The Impact of HIV/AIDS on Rural Households/Communities and the Need for Multisectoral Prevention and Mitigation Strategies to Combat the Epidemic in Rural Areas. Rome: Food and Agriculture Organization of the United Nations.
Ball TM, Holberg CJ, Aldous MB, Martinez FD, Wright AL. 2002. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med 156(2):121–6.
Barbour AG, Fish D. 1993. The biological and social phenomenon of Lyme disease. Science 260(5114):1610–6.
Barclay AJ, Foster A, Sommer A. 1987. Vitamin A supplements and mortality related to measles: a randomised clinical trial. Br Med J (Clin Res Ed) 294(6567):294–6.
Barragan A, Kremsner PG, Wahlgren M, Carlson J. 2000. Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting. Infect Immun 68(5):2971–5.
Bartlett JG, Breiman RF, Mandell LA, File TM Jr. 1998. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 26(4):811–38.
Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. 2000. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31(2):347–82.
Beard CB, Cordon–Rosales C, Durvasula RV. 2002. Bacterial symbionts of the triatominae and their potential use in control of Chagas disease transmission. Annu Rev Entomol 47:123–41.
Beaty BJ. 2000. Genetic manipulation of vectors: a potential novel approach for control of vector-borne diseases. Proc Natl Acad Sci U S A 97(19):10295–7.
Belgrader P, Benett W, Hadley D, Long G, Mariella R Jr, Milanovich F, Nasarabadi S, Nelson W, Richards J, Stratton P. 1998. Rapid pathogen detection using a microchip PCR array instrument. Clin Chem 44(10):2191–4.
Belgrader P, Hansford D, Kovacs GT, Venkateswaran K, Mariella R Jr, Milanovich F, Nasarabadi S, Okuzumi M, Pourahmadi F, Northrup MA. 1999a. A minisonicator to rapidly disrupt bacterial spores for DNA analysis. Anal Chem 71(19):4232–6.
Belgrader P, Benett W, Hadley D, Richards J, Stratton P, Mariella R Jr, Milanovich F. 1999b. PCR detection of bacteria in seven minutes. Science 284(5413):449–50.
Bellini WJ, Rota PA. 1998. Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis 4(1):29–35.
Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. 1997. Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med 337(6):388–94.
Beninati C, Oggioni MR, Boccanera M, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L. 2000. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol 18(10):1060–4.
Bergeron MG, Ouellette M. 1998. Preventing antibiotic resistance using rapid DNA-based diagnostic tests. Infect Control Hosp Epidemiol 19(8):560–4.
Berkman LF, Kawachi I, eds. 2000. Social Epidemiology. New York: Oxford University Press.
Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko DM. 1999. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 17(1):82– 94.
Bez C, Lodi G, Scully C, Porter SR. 2000. Genoprevalence of TT virus among clinical and auxiliary UK dental healthcare workers: a pilot study. Br Dent J 189(10):554–5.
Bhargava A, Jamison DT, Lau LJ, Murray CJ. 2001. Modeling the effects of health on economic growth. J Health Econ 20(3):423–40.
Black WC 4th, Baer CF, Antolin MF, DuTeau NM. 2001. Population genomics: genome-wide sampling of insect populations. Annu Rev Entomol 46:441–69.
Bloland PB. Drug Resistance in Malaria. 2001. Geneva: World Health Organization.
Bloom BR. 2002. Tuberculosis—the global view. N Engl J Med 346(19):1434–5.
Bloom DE, Sachs J. 1998. Geography, Demography, and Economic Growth in Africa. Brookings Papers on Economic Activity 2:207–295.
Blusch JH, Patience C, Martin U. 2002. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 9(4):242–51.
Boeing. 2002. Jetliner Safety: How Safe Is Flying. [Online]. Available: http://www.boeing.com/commercial/safety/pf/pf_howsafe.html.
Boete C, Koella JC. 2003. Evolutionary ideas about genetically manipulated mosquitoes and malaria control. Trends Parasitol 19(1):32–8.
Boone JD, Otteson EW, McGwire KC, Villard P, Rowe JE, St Jeor SC. 1998. Ecology and demographics of hantavirus infections in rodent populations in the Walker River Basin of Nevada and California. Am J Trop Med Hyg 59(3):445–51.
Braude R, Kon SK, Porter J. 1953. Antibiotics in nutrition. Nutr Abstr Rev 23:473–95.
Braunwald E, Fauci A, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. 2001. Harrison’s Principles of Internal Medicine. 15th ed. New York: McGraw–Hill Companies.
Brinton LA. 1992. The epidemiology of cervical cancer—overview. In: Munoz N, Bosch FX, Shah KV, Meheus A, eds. The Epidemiology of Cervical Cancer and Human Papillomavirus. Lyon, France: International Agency for Research in Cancer. Pp. 3–23.
Brinton LA, Reeves WC, Brenes MM, Herrero R, Gaitan E, Tenorio F, de Britton RC, Garcia M, Rawls WE. 1989a. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 44(2):199–203.
Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, Tenorio F, Garcia M, Rawls WE. 1989b. Parity as a risk factor for cervical cancer. Am J Epidemiol 130(3):486–96.
Bryan FL. 1982. Diseases transmitted by foods (A classification and summary). 2nd edition. U.S. Department of Heath and Human Services, Centers for Disease Control. Atlanta: HHS Pub No. (CDC) 84–8237.
Burton EC, Nemetz PN. 2000. Medical error and outcomes measures: where have all the autopsies gone? MedGenMed E8.
Buzby JC, Roberts T. 1997. Economic costs and trade impacts of microbial foodborne illness. World Health Stat Q 50(1–2):57–66.
Cairns L, Blythe D, Kao A, Pappagianis D, Kaufman L, Kobayashi J, Hajjeh R. 2000. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis 30(1):61–4.
Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, Persing DH. 2002. Host genetic polymorphism analysis in cervical cancer. Clin Chem 48(8): 1218–24.
Calisher CH, Root JJ, Mills JN, Beaty BJ. 2002. Assessment of ecologic and biologic factors leading to hantavirus pulmonary syndrome, Colorado, U.S.A. Croat Med J 43(3):330–7.
Campbell LA, Kuo CC, Grayston JT. 1998. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 4(4):571–9.
Campsmith ML, Nakashima AK, Jones JL. 2000. Association between crack cocaine use and high-risk sexual behaviors after HIV diagnosis. J Acquir Immune Defic Syndr 25(2):192–8.
Candinas D, Adams DH. 2000. Xenotransplantation: postponed by a millennium? QJM 93(2):63–6.
Carpenter C, Fayer R, Trout J, Beach MJ. 1999. Chlorine disinfection of recreational water for Cryptosporidium parvum. Emerg Infect Dis 5(4):579–84.
Carter R. 2001. Transmission blocking malaria vaccines. Vaccine 19(17–19):2309–14.
Cassell GH. 1998. Infectious causes of chronic inflammatory diseases and cancer. Emerg Infect Dis 4(3):475–87.
Cassell GH, Waites KB, Crouse DT. 1994. Mycoplasmal infections. In: Remington JS, KLein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia: WB Saunders Co. Pp. 619-656.
Castro-Leal F, Dayton J, Demery L, Mehra K. 2000. Public spending on health care in Africa: do the poor benefit? Bull World Health Org 78(1):66–74.
CDC. 1983. Epidemiologic notes and reports interstate importation of measles following transmission in an airport—California, Washington, 1982. MMWR 32(16):215–216.
CDC. 1984. Cryptosporidiosis among children attending day care centers—Georgia, Pennsylvania, Michigan, California, New Mexico. MMWR 33(42):599–601.
CDC. 1994a. Coccidioidomycosis following the Northridge Earthquake—California, 1994. MMWR 43(10):194–5.
CDC. 1994b. Outbreak of pneumonia associated with a cruise ship, 1994. MMWR 43(28): 521.
CDC. 1994c. Update: outbreak of Legionnaires’ disease associated with a cruise ship, 1994. MMWR 43(31):574–5.
CDC. 1994d. Update: human plague—India, 1994. MMWR 43(41):761–2.
CDC. 1995a. Outbreak of Ebola viral hemorrhagic fever—Zaire, 1995. MMWR 44(19):381– 2.
CDC. 1995b. Update: outbreak of Ebola viral hemorrhagic fever—Zaire, 1995. MMWR 44(25):468–9, 475.
CDC. 1997a. Reduced susceptibility of Staphylococcus aureus to vancomycin—Japan, 1996. MMWR 46(27):624–6.
CDC. 1997b. Update: Staphylococcus aureus with reduced susceptibility to vancomycin— United States, 1997. MMWR 46(35):813–5.
CDC. 1997c. Update: influenza activity—United States, 1997–1998 season. MMWR 46(46): 1094–8.
CDC. 1998a. Outbreak of Vibrio parahaemolyticus infections associated with eating raw oysters—Pacific Northwest, 1997. MMWR 47(22):457–62.
CDC. 1998b. Report to the State of Iowa Department of Public Health on the Investigation of the Chemical and Microbial Constituents of Ground and Surface Water Proximal to Large–Scale Swine Operations. Atlanta, GA: Centers for Disease Control and Prevention.
CDC. 1998c. Preventing emerging infectious diseases: a strategy for the 21st century. Overview of the updated CDC plan. MMWR 47(No. RR-15):1–14.
CDC. 1998d. Rubella among crew members of commercial cruise ships––Florida, 1997. MMWR 46(52–53):1247–50.
CDC. 1999a. Resurgent bacterial sexually transmitted disease among men who have sex with men—King County, Washington, 1997–1999. MMWR 48(35):773–7.
CDC. 1999b. Increases in unsafe sex and rectal gonorrhea among men who have sex with men—San Francisco, California, 1994–1997. MMWR 48(3):45–8.
CDC. 1999c. Outbreaks of Shigella sonnei infection associated with eating fresh parsley— United States and Canada, July–August 1998. MMWR 48(14):285–9.
CDC. 2000a. HIV/AIDS Surveillance Report. Atlanta, GA: Centers for Disease Control and Prevention. 12(2):1–44.
CDC. 2000b. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 49(RR–4):1–14.
CDC. 2000c. Outbreak of Rift Valley fever—Yemen, August–October 2000. MMWR 49(47): 1065–6.
CDC. 2000d. Serogroup W135 meningococcal disease among travelers returning from Saudi Arabia––United States, 2000. MMWR 49(16):345–6.
CDC. 2000e. Monitoring hospital-acquired infections to promote patient safety—United States, 1990–1999. MMWR 49(8):149–53.
CDC. 2000f. Integration Project: National Electronic Disease Surveillance System. [Online]. Available: http://www.cdc.gov/od/hissb/act_int.htm [accessed January 31, 2003].
CDC. 2001a. HIV/AIDS Surveillance Report. Atlanta, GA: Centers for Disease Control and Prevention. MMWR 13(2):1–44.
CDC. 2001b. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison—Mississippi, 2000. MMWR 50(42):919–22.
CDC. 2001c. Cancer Prevention and Control: Breast and Cervical Cancer Facts. The National Breast and Cervical Cancer Early Detection Program. [Online]. Available: http://www.cdc.gov/cancer/nbccedp/anniversary/facts.htm [accessed February 21, 2003].
CDC. 2001d. Outbreak of acute respiratory febrile illness among college students—Acapulco, Mexico, March 2001. MMWR 50(14):261–2.
CDC. 2001e. Mycotic Disease Listing. National Center for Infectious Diseases–Division of Bacterial and Mycotic Diseases. [Online]. Available: http://www.cdc.gov/ncidod/dbmd/ [accessed February 21, 2003].
CDC. 2001f. Sexually Transmitted Diseases Surveillance, 2000. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
CDC. 2001g. Risk for meningococcal disease associated with the Hajj 2001. MMWR 50(6): 97–8.
CDC. 2001h. Update: assessment of risk for meningococcal disease associated with the Hajj 2001. MMWR 50(12 ):221–2.
CDC. 2001i. Influenza B virus outbreak on a cruise ship—Northern Europe, 2000. MMWR 50(8):137–40.
CDC. 2001j. Importation of Nonhuman Primates: Foreign Quarantine regulations Relating to NHP (42CFR71.53). [Online]. Available: http://www.cdc.gov/ncidod/dq/nonhuman.htm [accessed February 18, 2003].
CDC. 2001k. Measles History. National Immunization Program. [Online]. Available: http://www.cdc.gov/nip/diseases/measles/history.htm [accessed February 18, 2003].
CDC. 2001l. Unexplained deaths following knee surgery—Minnesota, November 2001. MMWR 50(46):1035–6.
CDC. 2001m. Dengue Fever: CDC Dengue Fever Home Page. [Online]. Available: http://www.cdc.gov/ncidod/dvbid/dengue/ [accessed February 18, 2003].
CDC. 2001n. The Autopsy, Medicine, and Mortality Statistics. National Center for Health Statistics. Vital Health Stat 3(32).
CDC. 2001o. Public Health Action Plan to Combat Antimicrobial Resistance. National Center for Infectious Diseases, Centers for Disease Control and Prevention. Atlanta, GA [Online]. Available: http://www.cdc.gov/drugresistance/actionplan/html/index.htm [accessed January 30, 2003].
CDC. 2002a. Epidemiology and Prevention of Vaccine—Preventable Diseases. Washington, DC : Public Health Foundation.
CDC. 2002b. Smallpox Overview. [Online]. Available: http://www.bt.cdc.gov/agent/smallpox/overview/overview.pdf [accessed February 21, 2003].
CDC. 2002c. Local transmission of Plasmodium vivax Malaria—Virginia, 2002. MMWR 51:931–923.
CDC. 2002d. Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR 51(26):565–7.
CDC. 2002e. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae—Hawaii and California, 2001. MMWR 51(46):1041–1044.
CDC. 2002f. Drug-Associated HIV Transmission Continues in the United States. National Center for HIV, STD and TB Prevention–Division of HIV/AIDS Prevention. [Online]. Available: http://www.cdc.gov/hiv/pubs/facts/idu.htm [accessed February 14, 2003].
CDC. 2002g. Trends in sexual risk behaviors among high school students—United States, 1991–2001. MMWR 51(38):856–9.
CDC. 2002h. Sexually Transmitted Disease Surveillance, 2001. Atlanta: U.S. Department of Health and Human Services.
CDC. 2002i. Investigations of West Nile virus infections in recipients of blood transfusions. MMWR 51(43 ):973–4.
CDC. 2002j. Update: allograft-associated bacterial infections—United States, 2002. MMWR 51(10):207–10.
CDC. 2002l. Malaria surveillance—United States, 2000. MMWR 51(SS05):9–21.
CDC. 2002m. Outbreaks of gastroenteritis associated with noroviruses on cruise ships— United States, 2002. MMWR 51(49):1112–5.
CDC. 2002n. The National Molecular Subtyping Network for Foodborne Disease Surveillance. [Online]. Available: http://www.cdc.gov/pulsenet/index.htm [accessed February 18, 2003].
CDC. 2002o. Press Release: CDC Releases New Hand-Hygiene Guidelines. [Online]. Available: www.cdc.gov/od/oc/media/pressrel/r021025.htm [accessed February 18, 2003].
CDC. 2002p. Measles—United States, 2000. MMWR 51(6):120–3.
CDC. 2002q. Press Release: Measles no longer endemic in the United States. [Online]. Available: http://www.cdc.gov/od/oc/media/pressrel/r020429.htm [accessed February 21, 2003].
CDC. 2002r. Protecting the Nation’s health in an Era of Globalization. CDC’s Global Infectious Disease Strategy. Atlanta, GA: Center for Disease Control and Prevention.
CDC. 2002s. Programs in Brief Epidemic Information Exchange (Epi–X). [Online]. Available: http://www.cdc.gov/programs/research5.htm [accessed January 30, 2003].
CDC. 2002t. National Electronic Disease Surveillance System. [Online]. Available: http://www.cdc.gov/nedss/ [accessed January 31, 2003].
CDC. 2002u. National Center for Infectious Diseases: Surveillance Resources, Emerging Infections Program. [Online]. Available: http://www.cdc.gov/ncidod/osr/EIP.htm [accessed January 30, 2003].
CDC. 2002v. Special Pathogens Branch, Division of Viral and Rickettsial Diseases, unpublished data.
CDC. 2002w. New Variant CJD: Fact Sheet. [Online]. Available: http://www.cdc.gov/od/oc/media/pressrel/fs020418.htm [accessed February 27, 2003].
CDC. 2002x. All About Hantavirus. National Center for Infectious Diseases–Special Pathogens Branch. [Online]. Available: http://www.cdc.gov/ncidod/diseases/hanta/hps/noframes/hpsslideset/index.htm [accessed March 4, 2003].
CDC. 2003a. Biological Diseases/Agents. [Online]. Available: http://www.bt.cdc.gov/agent/agentlist.asp#categoryadiseases [accessed February 21, 2003].
CDC. 2003b. Nationally Notifiable Infectious Diseases. [Online]. Available: http://www.cdc.gov/epo/dphsi/PHS/infdis.htm [accessed January 30, 2003].
CDC. 2003c. West Nile Virus Update: Current Case Count. [Online]. Available: http://www.cdc.gov/od/oc/media/wncount.htm [accessed February 27, 2003].
Center for Infectious Disease Research and Policy (CIDRAP). 2002. Providing a Framework for Public Health Bioterrorism Preparedness: Public Health Workforce, Collaboration, and Infrastructure Issues. Washington, DC. [Online]. Available: http://www1.umn.edu/cidrap/center/mission/papers/btworkforce.html [accessed January 30, 2003].
Center for Science in the Public Interest (CSPI). 1998. Protecting the Crown Jewels: A Strategic Plan to Preserve the Effectiveness of Antibiotics. [Online]: Available: http://www.cspinet.org/reports/abiotic.htm [accessed January 30, 2003].
Chamberland ME, Epstein J, Dodd RY, Persing D, Will RG, DeMaria A Jr, Emmanuel JC, Pierce B, Khabbaz R. 1998. Blood safety. Emerg Infect Dis 4(3):410–1.
Chamberland ME, Alter HJ, Busch MP, Nemo G, Ricketts M. 2001. Emerging infectious disease issues in blood safety. Emerg Infect Dis 7(3 Suppl):552–3.
Chambers HF. 2001. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7(2):178–82.
Chandra RK. 1997. Nutrition and the immune system: an introduction. Am J Clin Nutr 66(2):460S–463S.
Chandrasekaran S, Lalithakumari D. 1998. Plasmid-mediated rifampicin resistance in Pseudomonas fluorescens. J Med Microbiol 47(3):197–200.
Chapman LE, Bloom ET. 2001. Clinical xenotransplantation. JAMA 285(18):2304–6.
Chee–Sanford JC, Aminov RI, Krapac IJ, Garrigues–Jeanjean N, Mackie RI. 2001. Occurrence and diversity of tetracycline resistance genes in lagoons and groundwater underlying two swine production facilities. Appl Environ Microbiol 67(4):1494–502.
Chen DK, McGeer A, de Azavedo JC, Low DE. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 341(4):233–9.
Chen Z, Ge Y, Landman N, Kang JX. 2002a. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells. BMC Cancer 2(1):18.
Chen SY, Gibson S, Katz MH, Klausner JD, Dilley JW, Schwarcz SK, Kellogg TA, McFarland W. 2002b. Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999–2001, USA. Am J Pub Health 92(9):1387–8.
Childs JE, Ksiazek TG, Spiropoulou CF, Krebs JW, Morzunov S, Maupin GO, Gage KL, Rollin PE, Sarisky J, Enscore RE, et al. 1994. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis 169(6):1271–80.
Chin J, ed. 2000. Control of Communicable Diseases Manual. 17th ed. Washington, DC: American Public Health Association.
Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, Goldsmith CS, Gubler DJ, Roehrig JT, Eaton B, Gould AR, et al. 2000. Nipah virus: a recently emergent deadly paramyxovirus. Science 288(5470):1432–5.
Chukwuani CM. 1999. Socio-economic implication of multi-drug resistant malaria in the community; how prepared is Nigeria for this emerging problem? West Afr J Med 18(4): 303–6.
Cohen ML. 2000. Changing patterns of infectious disease. Nature 406(6797):762–7.
Coker R. 2001. Control of tuberculosis in Russia. Lancet 358(9280):434–5.
Cole LA. 1997. The Eleventh Plague: The Politics of Biological and Chemical Warfare. New York: WH Freeman and Company.
Connolly M, Programme on Communicable Diseases in Complex Emergencies. 2002. Communicable diseases. Action Against Infection: A Newsletter for the World Health Organization and Its Partners 3(2):1–4.
Conway DJ, Roper C. 2000. Micro-evolution and emergence of pathogens. Int J Parasitol 30(12–13):1423–30.
Cooper RS, Osotimehin B, Kaufman JS, Forrester T. 1998. Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet 351(9097):208–10.
Coughlan E, Mindel A, Estcourt CS. 2001. Male clients of female commercial sex workers: HIV, STDs and risk behaviour. Int J STD AIDS 12(10):665–9.
Cox NJ, Subbarao K. 2000. Global epidemiology of influenza: past and present. Annu Rev Med 51:407–21.
Cunningham-Rundles S and Nesin M. 2000. Bacterial infections in the immunocompromised host. In: Nataro J, Blaser M, Cunningham-Rundles S, eds. Persistent Bacterial Infections. Washington, DC: ASM Press. Pp. 145–163.
Daar AS. 1999. Animal-to-human organ transplants—a solution or a new problem? Bull World Health Organ 77(1):54–61.
Danesh J, Newton R, Beral V. 1997. Epidemiology. A human germ project? Nature 389(6646):21, 23–4.
Davis CJ. 1999. Nuclear blindness: An overview of the biological weapons programs of the former Soviet Union and Iraq. Emerg Infect Dis 5(4):509–12.
Davis R, Kimball AM. 2001. The economics of emerging infections in the Asia Pacific region: what do we know and what do we need to know? In: Price-Smith AT, ed. Plagues and Politics: Infectious Disease and International Policy. New York: Palgrave Macmillan.
Day JF, Duxbury CV, Glasscock S, Pganessi JE. 2001. Removal trapping for the control of coastal biting midge populations. Technical Bulletin Florida Control Association 3:15– 16.
De Grandis SA, Stevenson RM. 1985. Antimicrobial susceptibility patterns and R plasmid– mediated resistance of the fish pathogen Yersinia ruckeri. Antimicrob Agents Chemother 27(6):938–42.
de The G. 1995. Viruses and human cancers: challenges for preventive strategies. Environ Health Perspect 103 Suppl 8:269–73.
De Tott F. 1973. Memoirs of Baron De Tott. New York: Arno Press.
Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, et al. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285(21):2763–73.
Denver Summit of the Eight. 1997. Communique. Denver, June 22, 1997. [Online] Available: http://usinfo.state.gov/topical/econ/group8/summit97/document.htm [accessed January 30, 2003].
Department of Defense–Global Emerging Infections System (DoD–GEISWeb). 2002. ESSENCE: Web Instructions. Electronic Surveillance System for the Early Notification of Community–Based Epidemics. [Online]. Available: http://www.geis.ha.osd.mil/GEIS/SurveillanceActivities/ESSENCE/ESSENCEinstructions.asp [accessed January 30, 2003].
DHHS (U.S. Department of Health and Human Services). 2000a. HHS Fact Sheet. HHS Guidelines for Xenotransplantation Safety. [Online]. Available: http://www.hhs.gov/news/press/2000pres/20000526.html [accessed March 4, 2003].
DHHS. 2000b. Healthy People 2010:2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: U.S. Government Printing Office.
DHHS, CDC, NIH. 1999. Biosafety in Microbiological and Biomedical Laboratories. 4th ed. HHS Publication No. (CDC) 93–8395. Washington, DC: U.S. Government Printing Office.
Diaz-Bonilla E, Babinard J, Pinstrup–Anderson P. 2001. Globalization and Health: A Survey of Opportunities and Risks for the Poor in Developing Counties. CMH Working Paper Series No. WG4:11. Cambridge, MA: Commission on Globalization and Health.
DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. 1991. Cost of innovation in the pharmaceutical industry. J Health Econ 10(2):107–42.
Dixon DM, McNeil MM, Cohen ML, Gellin BG, La Montagne JR. 1996. Fungal infections: a growing threat. Public Health Rep 111(3):226–35.
Dixon S, McDonald S, Roberts J. 2002. The impact of HIV and AIDS on Africa’s economic development. BMJ 324(7331):232–4.
Doebbeling BN, Stanley GL, Sheetz CT, Pfaller MA, Houston AK, Annis L, Li N, Wenzel RP. 1992. Comparative efficacy of alternative hand–washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 327(2):88–93.
Dumler JS, Valsamakis A. 1999. Molecular diagnostics for existing and emerging infections. Complementary tools for a new era of clinical microbiology. Am J Clin Pathol 112(Suppl 1):S33–9.
Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7):677–86.
Dyke MP, Grauaug A, Kohan R, Ott K, Andrews R. 1993. Ureaplasma urealyticum in a neonatal intensive care population. J Paediatr Child Health 29(4):295–7.
Eandi M, Zara GP. 1998. Economic impact of resistance in the community. Int J Clin Pract Suppl 95:27–38.
Economic Research Service. 2001. U.S. Department of Agriculture. Research Emphasis–food safety: features. [Online]. Available: http://www.ers.usda.gov/emphases/safefood/features.htm [accessed February 3, 2003].
Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C, Serrano Y, Inciardi JA, Bowser BP, Schilling RF, Holmberg SD. 1994. Intersecting epidemics—crack cocaine use and HIV infection among inner–city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med 331(21):1422–7.
Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. 1999. Nosocomial bloodstream infections in United States hospitals: a three–year analysis. Clin Infect Dis 29(2):239–44.
Effler P, Ching–Lee M, Bogard A, Ieong MC, Nekomoto T, Jernigan D. 1999. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods . JAMA 282(19):1845–50.
Ekeus R. 1999. Biological inspections in Iraq. In: Drell SD, Sofaer AD, Wilson GD, eds. The New Terror: Facing the Threat of Biological and Chemical Weapons. Stanford, CA: Hoover Institution Press. Pp. 237–254.
El Alamy MA, Cline BL. 1977. Prevalence and intensity of Schistosoma haematobium and S. mansoni infection in Qalyub, Egypt. Am J Trop Med Hyg 26(3):470–2.
Elder RO, Keen JE, Siragusa GR, Barkocy–Gallagher GA, Koohmaraie M, Laegreid WW. 2000. Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing. Proc Natl Acad Sci U S A 97(7):2999– 3003.
Elliott LH, Ksiazek TG, Rollin PE, Spiropoulou CF, Morzunov S, Monroe M, Goldsmith CS, Humphrey CD, Zaki SR, Krebs JW, et al. 1994. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg 51(1):102–8.
Emborg H, Ersboll AK, Heuer OE, Wegener HC. 2001. The effect of discontinuing the use of antimicrobial growth promoters on the productivity in the Danish broiler production. Prev Vet Med 50(1–2):53–70.
Epstein SE, Zhou YF, Zhu J. 1999. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100(4):e20–8.
Esiobu N, Armenta L, Ike J. 2002. Antibiotic resistance in soil and water environments. Int J Environ Health Res 12(2):133–44.
FAO (Food and Agriculture Organization of the United Nations). 2001. FAO Global Information and Early Warning System (GIEWS). Food supply situation and crop prospects in sub-Saharan Africa. Africa Report. No.1. Rome: FAO/GIEWS.
Farmer P. 1996. Social inequalities and emerging infectious diseases. Emerg Infect Dis 2(4): 259–69.
Fauci AS. 2001. Infectious diseases: considerations for the 21st century. Clin Infect Dis 32(5):675–85.
Fayer R. 2000. Presidential address. Global change and emerging infectious diseases. J Parasitol 86(6):1174–81.
Fayer R, Ungar BL. 1986. Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev 50(4): 458–83.
FDA (Food and Drug Administration). 2000. FDA Task Force on Antimicrobial Resistance: Key Recommendations and Report. Washington, DC. [Online]. Available: http://www.fda.gov/oc/antimicrobial/taskforce2000.html [accessed January 30, 2003].
FDA. 2001. Antibiotic resistance from down on the chicken farm. FDA Consumer Magazine. [Online]. Available: http://www.fda.gov/fdac/features/2001/101_chic.html [accessed March 4, 2003].
Federation of American Scientists (FAS). 2002. Crimean–Congo Hemorrhagic Fever and America’s War on Terrorism. [Online]. Available: http://www.fas.org/ahead/disease/cchf/outbreak/2001afg.htm [accessed February 10, 2003].
Feldman M, Cryer B, McArthur KE, Huet BA, Lee E. 1996. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 110(4):1043–52.
Fey PD, Safranek TJ, Rupp ME, Dunne EF, Ribot E, Iwen PC, Bradford PA, Angulo FJ, Hinrichs SH. 2000. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N Engl J Med 342(17):1242–9.
Field AK, Laughlin CA. 1999. In: Granoff A, Webster R, eds. Encyclopedia of Virology, vol. 1. 2nd ed. San Diego, CA: Academic Press. Pp. 54–68.
Fine A, Layton M. 2001. Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. Clin Infect Dis 32(2):277–82.
Fisher-Hoch SP, Tomori O, Nasidi A, Perez–Oronoz GI, Fakile Y, Hutwagner L, McCormick JB. 1995. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 311(7009):857–9.
Fleming DT, Wasserheit JN. 1999. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75(1):3–17.
Flint J, Harding RM, Boyce AJ, Clegg JB. 1993. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 6(1):215–62.
Focks DA, Daniels E, Haile DG, Keesling JE. 1995. A simulation model of the epidemiology of urban dengue fever: literature analysis, model development, preliminary validation, and samples of simulation results. Am J Trop Med Hyg 53(5):489–506.
Fonseca DM, Campbell S, Crans WJ, Mogi M, Miyagi I, Toma T, Bullians M, Andreadis TG, Berry RL, Pagac B, Sardelis MR, Wilkerson RC. 2001. Aedes (Finlaya) japonicus (Diptera: Culicidae), a newly recognized mosquito in the United States: analyses of genetic variation in the United States and putative source populations. J Med Entomol 38(2): 135–46.
Foy BD, Killeen GF, Magalhaes T, Beier JC. In press. Immunological targeting of critical insect antigens. Amer Entomol.
Francis E. 1921. Tularaemia: Francis 1921. I. The occurrence of tularemia in nature as a disease of Man. Public Helth Rep 36:1731–8.
Franco EL, Duarte–Franco E, Ferenczy A. 2001. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 164(7):1017–25.
Frank B. 2000. An overview of heroin trends in New York City: past, present and future. Mt Sinai J Med 67(5–6):340–6.
French GL, Ling J, Chow KL, Mark KK. 1987. Occurrence of multiple antibiotic resistance and R–plasmids in gram–negative bacteria isolated from faecally contaminated freshwater streams in Hong Kong. Epidemiol Infect 98(3):285–99.
Fuller R. 1989. Probiotics in man and animals. J Appl Bacteriol 66(5):365–78.
Galambos L, Sewell JE. 1995. Networks of Innovation: Vaccine Development at Merck, Sharp & Dohme, and Mulford, 1895–1995. New York: Cambridge University Press.
Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, Courvalin P. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 337(10):677–80.
Gant V, Parton S. 2000. Community-acquired pneumonia. Curr Opin Pulm Med 6(3):226– 33.
GAO (U.S. General Accounting Office). 1995. Animal agriculture: information on waste management and water quality issues. GAO/RCED–95–200BR. Washington, DC: GAO.
GAO. 1999. Food Safety: The Agricultural Use of Antibiotics and Its Implications for Human Health. GAO/RCED–99–74. Washington, DC: GAO.
GAO. 2002. Childhood Vaccines: Challenges in Preventing Future Shortages. Statement of Janet Heinrich, Director, Health Care–Public Health Issues. Testimony before the Sub-committee on Public Health, Committee on Health, Education, Labor, and Pensions, US Senate. GAO–02–1105T. Washington, DC: GAO
Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, O’Brien SJ, Carrington M. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344(22):1668–75.
Garcia–Sastre A. 2002. Mechanisms of inhibition of the host interferon alpha/beta–mediated antiviral responses by viruses. Microbes Infect 4(6):647–55.
Garrett ES, dos Santos CL, Jahncke ML. 1997. Public, animal, and environmental health implications of aquaculture. Emerg Infect Dis 3(4):453–7.
Garrett L. 1989. Emerging viruses, growing concerns. Newsday 30:1.
Garrett L. 1995. The Coming Plague. New York: Penguin Books.
Garrett L. 1998. Social, behavioral, and demographic factors in emerging infections. J Urban Health 75(3):492–500.
Gewolb J, ed. 2001. Random samples: the perils of pilgrimage. Science 294(5550):2285.
Gilmore Commission. 2000. Second Annual Report of the Advisory Panel to Assess Domestic Response Capabilities for Terrorism Involving Weapons of Mass Destruction. Toward a National Strategy for Combating Terrorism. Arlington, VA: RAND.
Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double–blind, placebo-controlled trial. Gastroenterology 119(2): 305–9.
Glass GE, Watson AJ, LeDuc JW, Childs JE. 1994. Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron 68(1):48–51.
Glass GE, Cheek JE, Patz JA, Shields TM, Doyle TJ, Thoroughman DA, Hunt DK, Enscore RE, Gage KL, Irland C, Peters CJ, Bryan R. 2000. Using remotely sensed data to identify areas at risk for hantavirus pulmonary syndrome. Emerg Infect Dis 6(3):238–47.
Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK. 2000. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med 342(17):1229–35.
GOMA Epidemiology Group. 1995. Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Goma Epidemiology Group. Lancet 345(8946): 339–44.
Gonzales R, Malone DC, Maselli JH, Sande MA. 2001. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 33(6):757–62.
Gorbach SL. 2001. Antimicrobial use in animal feed-time to stop. N Engl J Med 345(16): 1202–3.
Gorrochotequi-Escalante N, Gomez-Machorro C, Lozano-Fuentes S, Fernandez-Salas I, De Lourdes, Munoz M, Farfan-Ale J, Beaty BJ, Black WC. 2002. The breeding structure of Aedes aegypti populations in Mexico varies by region. Am J Trop Med Hyg 66(2):213-22.
Gostin LO. 2001a. Public health law reform. Am J Pub Health 91(9):1365–8.
Gostin LO. 2001b. Public Health Law: Power, Duty, Restraint. Berkeley and New York: University of California Press and Milbank Memorial Fund.
Gostin LO. 2002. Public Health Law and Ethics: A Reader. Berkeley and New York: University of California Press and Milbank Memorial Fund.
Gostin LO, Burris S, Lazzarini Z. 1999. The law and the public’s health: a study of infectious disease law in the United States. Columbia Law Rev 99(1):59–128.
Gostin LO, Sapsin JW, Teret SP, Burris S, Mair JS, Hodge JG Jr, Vernick JS. 2002. The Model State Emergency Health Powers Act: planning for and response to bioterrorism and naturally occurring infectious diseases. JAMA 288(5):622–8.
Grattan LM, Oldach D, Perl TM, Lowitt MH, Matuszak DL, Dickson C, Parrott C, Shoemaker RC, Kauffman CL, Wasserman MP, Hebel JR, Charache P, Morris JG Jr. 1998. Learning and memory difficulties after environmental exposure to waterways containing toxin–producing Pfiesteria or Pfiesteria–like dinoflagellates. Lancet 352(9127):532–9.
Gratz NG. 1999. Emerging and resurging vector-borne diseases. Annu Rev Entomol 44:51– 75.
Gray MW, Burger G, Lang BF. 1999. Mitochondrial evolution. Science 283(5407):1476–81.
Greenberg BL, Semba RD, Vink PE, Farley JJ, Sivapalasingam M, Steketee RW, Thea DM, Schoenbaum EE. 1997. Vitamin A deficiency and maternal–infant transmissions of HIV in two metropolitan areas in the United States. AIDS 11(3):325–32.
Greenko JA, Mostashari F, Fine A, Layton M. 2002 (March 24–27). Clinical validation study of the EMS 911 syndromic surveillance system for bioterrorism or pandemic influenza in New York City. International Conference on Emerging Infectious Diseases. Atlanta. CDC.
Griffin DW, Kellogg CA, Shinn EA. 2001. Dust in the wind: Long range transport of dust in the atmosphere and its implications for global public and ecosystem health. Global Change and Human Health 2(1):20–33.
Groisman EA, Ochman H. 1996. Pathogenicity islands: bacterial evolution in quantum leaps. Cell 87(5):791–4.
Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D, Moore KA, Cheek JE. 2001. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286(10):1201–5.
Gruebler A, Nakicenovic N. 1991. The Evolution of Transport Systems: Past and Future. Research Report RR–91–008. Laxenburg, Vienna: International Institute for Applied Systems Analysis.
Gryseels B, Stelma FF, Talla I, van Dam GJ, Polman K, Sow S, Diaw M, Sturrock RF, Doehring–Schwerdtfeger E, Kardorff R, et al. 1994. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop Geogr Med 46(4 Spec No):209–19.
Gubareva LV, Robinson MJ, Bethell RC, Webster RG. 1997. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino–Neu5Ac2en. J Virol 71(5):3385–90.
Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG. 1998. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 178(5):1257–62.
Gubareva LV, Kaiser L, Hayden FG. 2000. Influenza virus neuraminidase inhibitors. Lancet 355(9206):827–35.
Gubler DJ. 1998. Resurgent vector-borne diseases as a global health problem. Emerg Infect Dis 4(3):442–50.
Gubler DJ. 2001. Human arbovirus infections worldwide. Ann N Y Acad Sci 951:13–24.
Gubler DJ. 2002. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10(2):100–3.
Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621–67.
Guerrant RL, Schorling JB, McAuliffe JF, de Souza MA. 1992. Diarrhea as a cause and an effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration. Am J Trop Med Hyg 47(1 Pt 2):28–35.
Gunn RA, Montes JM, Toomey KE, Rolfs RT, Greenspan JR, Spitters CE, Waterman SH. 1995. Syphilis in San Diego County 1983–1992: crack cocaine, prostitution, and the limitations of partner notification. Sex Transm Dis 22(1):60–6.
Gustafson P, Gomes VF, Vieira CS, Jensen H, Seng R, Norberg R, Samb B, Naucler A, Aaby P. 2001. Tuberculosis mortality during a civil war in Guinea–Bissau. JAMA 286(5):599– 603.
Gwatkin DR. 2000. Health inequalities and the health of the poor: what do we know? What can we do? Bull World Health Organ 78(1):3–18.
Gwatkin DR, Guillot M, Heuveline P. 1999. The burden of disease among the global poor. Lancet 354(9178):586–9.
Hacker J, Kaper JB. 2000. Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 54:641–79.
Hacker J, Blum–Oehler G, Muhldorfer I, Tschape H. 1997. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 23(6): 1089–97.
Haldane JBS. 1949. Disease and Evolution. La Ricerca Scientifica Suppl A(19):68–76.
Hamblin MT, Thompson EE, Di Rienzo A. 2002. Complex signatures of natural selection at the Duffy blood group locus. Am J Hum Genet 70(2):369–83.
Hamscher G, Sczesny S, Hoper H, Nau H. 2002. Determination of persistent tetracycline residues in soil fertilized with liquid manure by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Anal Chem 74(7):1509–18.
Handszuh, HF, Chief, Quality of Tourism Development. 2001 (February 22–23). Symposium on Tourism Services. Geneva. World Tourism Organization (WTO-OMT).
Hansen RW. 1979. The pharmaceutical development process: estimates of current development costs and times and the effects of regulatory changes. In: Chien RI, ed. Issues in Pharmaceutical Economics. Lexington, MA: Lexington Books. Pp.151–187.
Hanzlick R, Baker P. 1998. Case of the month: institutional autopsy rates. Autopsy Committee of the College of American Pathologists. Arch Intern Med 158(11):1171–2.
Harries AD, Maher D. 1996. TB/HIV A Clinical Manual. Geneva: WHO.
Haruma K, Kamada T, Kawaguchi H, Okamoto S, Yoshihara M, Sumii K, Inoue M, Kishimoto S, Kajiyama G, Miyoshi A. 2000. Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol 15(3):277–83.
Hasson J, Schneiderman H. 1995. Autopsy training programs. To right a wrong. Arch Pathol Lab Med 119(3):289–91.
Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4(11):3021–4.
Hayden FG. 2001. Perspectives on antiviral use during pandemic influenza. Philos Trans R Soc Lond B Biol Sci 356(1416):1877–84.
Hayden FG, Hay AJ. 1992. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol 176:119–30.
Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE. 1999. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282(13):1240–6.
Hearst N, Mandel JS, Coates TJ. 1995. Collaborative AIDS prevention research in the developing world: the CAPS experience. AIDS 9 Suppl 1:S1–5.
Hedberg CW, MacDonald KL, Osterholm MT. 1994. Changing epidemiology of food-borne disease: a Minnesota perspective. Clin Infect Dis 18(5):671–80; quiz 681–2.
Helminen ME, Kilpinen S, Virta M, Hurme M. 2001. Susceptibility to primary Epstein–Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 184(6):777–80.
Henderson DA. 1999. The looming threat of bioterrorism. Science 283(5406):1279–82.
Henderson DA, Moss B. 1999. Smallpox and vaccinia. In: Plotkin SA, Orenstein O, eds. Vaccines. 3rd ed. Philadelphia: WB Saunders Company.
Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O’Toole T, Parker G, Perl T, Russell PK, Tonat K. 1999. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281(22):2127–37.
Henderson FW, Clyde WA Jr, Collier AM, Denny FW, Senior RJ, Sheaffer CI, Conley WG 3rd, Christian RM. 1979. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr 95(2):183–90.
Herlocher ML, Carr J, Ives J, Elias S, Truscon R, Roberts N, Monto AS. 2002. Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antiviral Res 54(2):99–111.
Herrero IA, Issa NC, Patel R. 2002. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 346(11):867–9.
Herrero R. 1996. Epidemiology of cervical cancer. J Natl Cancer Inst Monogr (21):1–6.
Hersh SM. 1968. Chemical and Biological Warfare: America’s Hidden Arsenal. New York: Bobbs–Merrill Company, Inc.
Herwaldt BL, Ackers ML. 1997. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. The Cyclospora Working Group. N Engl J Med 336(22):1548–56.
Herwaldt BL, Beach MJ. 1999. The return of cyclospora in 1997: another outbreak of cyclosporiasis in North America associated with imported raspberries. Cyclospora Working Group. Ann Intern Med 130(3):210–20.
Heymann DL. 2001 (September 5). Strengthening Global Preparedness for Defense Against Infectious Disease Threats. Statement by Executive Director for Communicable Diseases WHO.
Hill AV. 1998. The immunogenetics of human infectious diseases. Annu Rev Immunol 16: 593–617.
Hill AV. 2001. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet 2:373–400.
Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM. 1991. Common west African HLA antigens are associated with protection from severe malaria. Nature 352(6336):595–600.
Hill CA, Fox AN, Pitts RJ, Kent LB, Tan PL, Chrystal MA, Cravchik A, Collins FH, Robertson HM, Zwiebel LJ. 2002. G protein-coupled receptors in Anopheles gambiae. Science 298(5591):176–8.
Hjelle B, Glass GE. 2000. Outbreak of hantavirus infection in the Four Corners region of the United States in the wake of the 1997–1998 El Nino–southern oscillation . J Infect Dis 181(5):1569–73.
Ho GY, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL. 1998. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 78(3):281–5.
Hodge JG Jr. 2002. West Nile Virus in the United States: A State of the Art Assessment of Law and Policy. Baltimore and Washington, DC: Center for Law and the Public’s Health.
Holly EA. 1996. Cervical intraepithelial neoplasia, cervical cancer, and HPV. Annu Rev Public Health 17:69–84.
Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, Nusskern DR, Wincker P, Clark AG, Ribeiro JM, Wides R, Salzberg SL, Loftus B, Yandell M, et al. 2002. The genome sequence of the malaria mosquito Anopheles gambiae. Science 298(5591):129– 49.
Holtgrave DR, Pinkerton SD. 2000. Consequences of HIV prevention interventions and programs: spectrum, selection, and quality of outcome measures. AIDS 14 Suppl 2:S27–33.
Holtz TH, Kachur SP, MacArthur JR, Roberts JM, Barber AM, Steketee RW, Parise ME. 2001. Malaria surveillance–United States, 1998. MMWR CDC Surveill Summ 50(5):1– 20.
Hooper LV, Gordon JI. 2001. Commensal host–bacterial relationships in the gut. Science 292(5519):1115–8.
Houweling TA, Kunst AE, Mackenbach JP. 2001. World Health Report 2000: inequality index and socioeconomic inequalities in mortality. Lancet 357(9269):1671–2.
Hoxie NJ, Davis JP, Vergeront JM, Nashold RD, Blair KA. 1997. Cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin. Am J Public Health 87(12):2032–5.
Huebner DM, Gerend MA. 2001. The relation between beliefs about drug treatments for HIV and sexual risk behavior in gay and bisexual men. Ann Behav Med 23(4):304–12.
Humane Society of the United States. 2001. The trade in live reptiles: imports to the United States. Washington, DC: Humane Society.
Humane Society of the United States. 2002. Fast–Food Restaurants Curbing Antibiotics in Poultry. [Online]. Available: http://www.hsus.org/ace/13383 [accessed March 5, 2003].
Humphrey RW, Davis DA, Newcomb FM, Yarchoan R. 1998. Human herpesvirus 8 (HHV– 8) in the pathogenesis of Kaposi’s sarcoma and other diseases. Leuk Lymphoma 28(3– 4):255–64.
Hunter CA, Reiner SL. 2000. Cytokines and T cells in host defense. Curr Opin Immunol 12(4):413–8.
Hyder AA, Morrow RH. 2000. Applying burden of disease methods in developing countries: a case study from Pakistan. Am J Pub Health 90(8):1235–40.
Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, et al. 2000. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 283(17):2281–90.
Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, et al. 2002. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287(17):2236–52.
Intergovernmental Panel on Climate Change (IPCC). 2001a. Climate Change 2001: The Scientific Basis. Contribution of Working Group I to the Third Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge, UK: Cambridge University Press.
IPCC. 2001b. Climate Change 2001: Impacts, Adaptation and Vulnerability. Contribution of Working Group II to the Third Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge, UK: Cambridge University Press.
International Agency for Research on Cancer Working Group. 1995. Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 64. Lyon: International Agency for Research on Cancer.
International Society for Infectious Diseases (ISID). 2001. ProMED–mail. [Online]. Available: http://www.promedmail.org/pls/askus/f?p=2400:1000 [accessed January 30, 2003].
IOM. 1988. The Future of Public Health. Washington, DC: National Academy Press.
IOM. 1991. Malaria: Obstacles and Opportunities. Washington, DC: National Academy Press.
IOM. 1992. Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press.
IOM. 1996. Xenotransplantation: Science, Ethics, and Public Policy. Washington, DC: National Academy Press.
IOM. 1997. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press.
IOM. 1999a. Assessment of Future Needs for Live Variola Virus. Washington, DC: National Academy Press.
IOM. 1999b. The Use of Drugs in Food Animals: Benefits and Risks. Washington, DC: National Academy Press.
IOM. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary. Washington, DC: National Academy Press.
IOM. 2001b. Emerging Infectious Diseases from the Global to the Local Perspective. Washington, DC: National Academy Press.
IOM. 2001c. Firepower in the Lab: Automation in the Fight Against Infectious Disease and Bioterrorism. Washington, DC: National Academy Press.
IOM. 2001d. Vaccines for the 21st Century: A Tool for Decisionmaking. Washington, DC: National Academy Press.
IOM. 2001e. Perspectives on the Department of Defense Global Emerging Infections Surveillance and Response System: A Program Review. Washington, DC: National Academy Press.
IOM. 2002a. Biological Threats and Terrorism: Assessing the Science and Response Capabilities, Workshop Summary. Washington, DC: National Academy Press.
IOM. 2002b. Considerations for Viral Disease Eradication. Washington, DC: National Academy Press.
IOM. 2002c. Dietary Reference Intake for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press.
IOM. 2002d. The Emergence of Zoonotic Diseases: Understanding the Impact on Animal and Human Health. Washington, DC: National Academy Press.
IOM. 2002e. Who Will Keep the Public Healthy? Educating Public Health Professionals for the 21st Century. Washington, DC: National Academy Press.
IOM. 2003. Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report #1. Washington, DC: National Academy Press.
Ito J, Ghosh A, Moreira LA, Wimmer EA, Jacobs-Lorena M. 2002. Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite. Nature 417(6887):452–455.
Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, Nagley D, Johnson E, Jaax G, Peters C. 1995. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 346(8991–8992):1669–71.
Jaramillo E. 2002. DOTS–Plus & the Green Light Committee. Presentation at “Meet the Expert” Session of the 33rd IUATLD World Conference on Lung Health, Montreal. Palais de Congres. WHO/CDS/STB/TBS.
Jarvis WR. 1994. Handwashing—the Semmelweis lesson forgotten? Lancet 344(8933):1311– 2.
Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Cetron M, Cohen M, Doyle T, Fischer M, Greene C, Griffith KS, Guarner J, Hadler JL et al. 2002. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 8(10):1019–28.
Jeronimo SM, Oliveira RM, Mackay S, Costa RM, Sweet J, Nascimento ET, Luz KG, Fernandes MZ, Jernigan J, Pearson RD. 1994. An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans R Soc Trop Med Hyg 88(4):386–8.
Jones OA, Voulvoulis N, Lester JN. 2001. Human pharmaceuticals in the aquatic environment a review. Environ Technol 22(12):1383–94.
Jones TF, Kellum ME, Porter SS, Bell M, Schaffner W. 2002. An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 8(1):82–4.
Junger S. 1998. The Perfect Storm. New York: HarperPaperbacks, A Division of Harper CollinsPublishers.
Kadlec RP, Zelicoff AP, Vrtis AM. 1999. Biological weapons control: prospects and implications for the future. In: Lederberg J, ed. Biological Weapons: Limiting the Threat. Cambridge, MA: MIT Press. Pp. 95–111.
Kalipeni E, Oppong J. 1998. The refugee crisis in Africa and implications for health and disease: a political ecology approach. Soc Sci Med 46(12):1637–53.
Kamhawi S, Belkaid Y, Modi G, Rowton E, Sacks D. 2000. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science 290(5495):1351–4.
Kapadia F, Vlahov D, Des Jarlais DC, Strathdee SA, Ouellet L, Kerndt P, Morse EV, Williams I, Garfein RS. 2002. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology 13(6):738–41.
Karon JM, Fleming PL, Steketee RW, De Cock KM. 2001. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 91(7):1060–8.
Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O’Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, Mann DL. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection. Nat Med 2(4):405–11.
Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, Gibson S, McFarland W. 2002. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Pub Health 92(3):388–94.
Kelch WJ, Lee JS. 1978. Antibiotic resistance patterns of gram–negative bacteria isolated from environmental sources. Appl Environ Microbiol 36(3):450–6.
Kemp E. 1996. Xenotransplantation. J Intern Med 239(4):287–97.
Kenny GE, Kuo C. 2000. Infection and chronic disease. Washington Public Health:1–4.
Kenyon TA, Valway SE, Ihle WW, Onorato IM, Castro KG. 1996. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 334(15):933–8.
Khan IM, Laaser U. 2002. Burden of tuberculosis in Afghanistan: update on a war-stricken country. Croat Med J 43(2):245–7.
Kilbourne ED, Cerini CP, Khan MW, Mitchell JW Jr, Ogra PL. 1987. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. J Immunol 138(9):3010–3.
Kilmarx PH, Knapp JS, Xia M, St Louis ME, Neal SW, Sayers D, Doyle LJ, Roberts MC, Whittington WL. 1998. Intercity spread of gonococci with decreased susceptibility to fluoroquinolones: a unique focus in the United States. J Infect Dis 177(3):677–82.
Kim J, Nietfeldt J, Ju J, Wise J, Fegan N, Desmarchelier P, Benson AK. 2001. Ancestral divergence, genome diversification, and phylogeographic variation in subpopulations of sorbitol-negative, beta-glucuronidase-negative enterohemorrhagic Escherichia coli O157. J Bacteriol 183(23):6885–97.
Kim JY, Shakow ADA, Bayona J. 1999. The privatization of health care in Peru. Development 42(4):121–125.
Kinsella K, Velkoff VA. 2001. An Aging World: 2001. U.S. Census Bureau, Series P95/01–1. Washington, DC: U.S. Government Printing Office.
Klein G, Powers A, Croce C. 2002. Association of SV40 with human tumors. Oncogene 21(8):1141–9.
Klein JO. 1986. Infectious diseases and day care. Rev Infect Dis 8(4):521–6.
Klenerman P, Cerundolo V, Dunbar PR. 2002. Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol 2(4):263–72.
Klug SJ, Wilmotte R, Santos C, Almonte M, Herrero R, Guerrero I, Caceres E, Peixoto– Guimaraes D, Lenoir G, Hainaut P, Walboomers JM, Munoz N. 2001. TP53 polymorphism, HPV infection, and risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 10(9):1009–12.
Koumans EH, Katz DJ, Malecki JM, Kumar S, Wahlquist SP, Arrowood MJ, Hightower AW, Herwaldt BL. 1998. An outbreak of cyclosporiasis in Florida in 1995: a harbinger of multistate outbreaks in 1996 and 1997. Am J Trop Med Hyg 59(2):235–42.
Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327(18):1272–8.
Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347(21):1645–51.
Kummerer K. 2000. Drugs, diagnostic agents and disinfectants in wastewater and water—a review. Schriftenr Ver Wasser Boden Lufthyg 105:59–71.
Kurstak E, ed. 1993. Control of Virus Diseases. New York: Marcel Dekker, Inc.
Lamb RA, Krug RM. 2001. Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins.
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409(6822):860–921.
Lange WR, Ball JC, Pfeiffer MB, Snyder FR, Cone EJ. 1989. The Lexington addicts, 1971– 1972: demographic characteristics, drug use patterns, and selected infectious disease experience. Int J Addict 24(7):609–26.
Lederberg J. 1999. J.B.S. Haldane (1949) on infectious disease and evolution. Genetics 153(1):1–3.
Lederberg J. 2000. Infectious history. Science 288(5464):287–93.
Levander OA. 1997. Nutrition and newly emerging viral diseases: an overview. J Nutr 127(5 Suppl):948S–950S.
Leverstein–van Hall MA, Box AT, Blok HE, Paauw A, Fluit AC, Verhoef J. 2002. Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant enterobacteriaceae in a clinical setting. J Infect Dis 186(1):49–56.
Liang AP, Koopmans M, Doyle MP, Bernard DT, Brewer CE. 2001. Teaming up to prevent foodborne disease. Emerg Infect Dis 7(3 Suppl):533–4.
Liaw KL, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, Burk RD, Kurman RJ, Wacholder S, Rush BB, Cadell DM, Lawler P, Tabor D, Schiffman M. 1999. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 91(11):954–60.
Lima AA, Fang G, Schorling JB, de Albuquerque L, McAuliffe JF, Mota S, Leite R, Guerrant RL. 1992. Persistent diarrhea in northeast Brazil: etiologies and interactions with malnutrition. Acta Paediatr Suppl 381:39–44.
Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ. 1999. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 285(5426): 397–400.
LoGiudice K, Ostfeld RS, Schmidt KA, Keesing F. 2003. The ecology of infectious disease: effects of host diversity and community composition on Lyme disease risk. Proc Natl Acad Sci U S A 100(2):567–71.
Lounibos LP. 2002. Invasions by insect vectors of human disease. Annu Rev Entomol 47:233– 66.
MacKenzie WR, Hoxie NJ, Proctor ME, Gradus MS, Blair KA, Peterson DE, Kazmierczak JJ, Addiss DG, Fox KR, Rose JB. 1994. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 331(3): 161–7.
Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl–Erler ML. 2000. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 9(11): 1183–91.
Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV. 1996. Reported cholera in the United States, 1992–1994: a reflection of global changes in cholera epidemiology. JAMA 276(4):307–12.
Mansergh G, Colfax GN, Marks G, Rader M, Guzman R, Buchbinder S. 2001. The Circuit Party Men’s Health Survey: findings and implications for gay and bisexual men. Am J Public Health 91(6):953–8.
Mansky LM, Temin HM. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69(8):5087–94.
Marinella MA, Pierson C, Chenoweth C. 1997. The stethoscope. A potential source of nosocomial infection? Arch Intern Med 157(7):786–90.
Marshall BJ. 1989. History of the discovery of C. pylori. In: Blaser MJ, ed. Camplobacter Pylori in Gastritis and Peptic Ulcer Disease. New York: Igaku-Shoin. Pp. 7–23.
Martens P, Hall L. 2000. Malaria on the move: human population movement and malaria transmission. Emerg Infect Dis 6(2):103–9.
Mata L. 1992. Diarrheal disease as a cause of malnutrition. Am J Trop Med Hyg 47(1 Pt 2):16–27.
Mata LJ, Kromal RA, Urrutia JJ, Garcia B. 1977. Effect of infection on food intake and the nutritional state: perspectives as viewed from the village. Am J Clin Nutr 30(8):1215– 27.
Mattison AM, Ross MW, Wolfson T, Franklin D. 2001. Circuit party attendance, club drug use, and unsafe sex in gay men. J Subst Abuse 13(1–2):119–26.
Mavroidi A, Tzouvelekis LS, Tassios PT, Flemetakis A, Daniilidou M, Tzelepi E. 2000. Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999. J Clin Microbiol 38(9):3489–91.
Mayer JD. 2000. Geography, ecology and emerging infectious diseases. Soc Sci Med 50(7– 8):937–52.
McCarthy M. 2002. US FDA orders transplant tissue recall. Lancet 360(9333):623.
McDaniel TK, Kaper JB. 1997. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K–12. Mol Microbiol 23(2):399–407.
McDermott J. 1987. The Killing Winds: The Menace of Biological Warfare. New York: Arbor House.
McDonald LC, Rossiter S, Mackinson C, Wang YY, Johnson S, Sullivan M, Sokolow R, DeBess E, Gilbert L, Benson JA, Hill B, Angulo FJ. 2001. Quinupristin–dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med 345(16):1155–60.
McEwen SA, Fedorka-Cray PJ. 2002. Antimicrobial use and resistance in animals. Clin Infect Dis 34 (Suppl 3):S93–S106.
McIlhaney JS Jr. 2000. Sexually transmitted infection and teenage sexuality. Am J Obstet Gynecol 183(2):334–9.
McKimm-Breschkin JL, McDonald M, Blick TJ, Colman PM. 1996. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4–guanidino–Neu5Ac2en leads to instability of the enzyme. Virology 225(1): 240–2.
Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV. 1999. Food-related illness and death in the United States. Emerg Infect Dis 5(5):607–25.
Mercado R. 1975. Rodent control programmes in areas affected by Bolivian haemorrhagic fever. Bull World Health Org 52(4–6):691–6.
Meselson M, Guillemin J, Hugh–Jones M, Langmuir A, Popova I, Shelokov A, Yampolskaya O. 1994. The Sverdlovsk anthrax outbreak of 1979. Science 266(5188):1202–8.
Miller JM, Tam TW, Maloney S, Fukuda K, Cox N, Hockin J, Kertesz D, Klimov A, Cetron M. 2000. Cruise ships: high–risk passengers and the global spread of new influenza viruses. Clin Infect Dis 31(2):433–8.
Miller LH. 1994. Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc Natl Acad Sci U S A 91(7):2415–9.
Mills JN, Childs JE. 1998. Ecologic studies of rodent reservoirs: their relevance for human health. Emerg Infect Dis 4(4):529–37.
Mills JN, Ellis BA, McKee KT Jr, Calderon GE, Maiztegui JI, Nelson GO, Ksiazek TG, Peters CJ, Childs JE. 1992. A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am J Trop Med Hyg 47(6):749–63.
Mills JN, Yates T.L., Ksiazek TG, Peters CJ, Childs JE. 1999. Long–term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis 5(1):135–42.
Moller H, Heseltine E, Vainio H. 1995. Working group report on schistosomes, liver flukes and Helicobacter pylori. Int J Cancer 60(5):587–9.
Monath TP. 1993. Arthropod–borne viruses. In: Morse SS, ed. Emerging Viruses. New York: Oxford University Press.
Monath TP. 2001. Yellow fever: an update. Lancet Infect Dis 1(1):11–20.
Monath TP, Cetron MS. 2002. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34(10):1369–78.
Monitoring the AIDS Pandemic Network. 2000 (July 9-14). The Status and Trends of the HIV/AIDS in the World Symposium of the XIIIth International AIDS Conference. Washington, DC: MAP.
Monroe MC, Morzunov SP, Johnson AM, Bowen MD, Artsob H, Yates T, Peters CJ, Rollin PE, Ksiazek TG, Nichol ST. 1999. Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis 5(1):75–86.
Moore CG. 1999. Aedes albopictus in the United States: current status and prospects for further spread. J Am Mosq Control Assoc 15(2):221–7.
Morris CN, Burdge DR, Cheevers EJ. 2000. Economic impact of HIV infection in a cohort of male sugar mill workers in South Africa from the perspective of industry. Unpublished.
Morris JG, Potter M. 1997. Emergence of new pathogens as a function of changes in host susceptibility. Emerg Infect Dis 3(4):435–41.
Morse D, Brothwell DR, Ucko PJ. 1964. Tuberculosis in ancient Egypt. Ann Rev Respir Dis 90:524–541.
Morse SS. 1995. Factors in the emergence of infectious diseases. Emerg Infect Dis 1(1):7–15.
Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J. 2001. Risks for incident human papillomavirus infection and low–grade squamous intraepithelial lesion development in young females. JAMA 285(23):2995–3002.
Moser MR, Bender TR, Margolis HS, Noble GR, Kendal AP, Ritter DG. 1979. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 110(1):1–6.
Moss B. 1996. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci U S A 93(21):11341–8.
Moss B, Shisler JL. 2001. Immunology 101 at poxvirus U: immune evasion genes. Semin Immunol 13(1):59–66.
Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, Katz N, Liljebjelke KA, Biggerstaff BJ, Fine AD, Layton MC, Mullin SM, Johnson AJ, Martin DA, Hayes EB, Campbell GL. 2001. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358(9278):261–4.
Mukadi YD, Maher D, Harries A. 2001. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 15(2):143–52.
Mukamolova GV, Kaprelyants AS, Young DI, Young M, Kell DB. 1998. A bacterial cytokine. Proc Natl Acad Sci U S A 95(15):8916–21.
Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, et al. 1992. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52(5):743–9.
Murray CJ, Lopez AD. 1997. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349(9061):1269–76.
Murray CJ, King G, Lopez AD, Tomijima N, Krug EG. 2002. Armed conflict as a public health problem. BMJ 324(7333):346–9.
Myung PS, Boerthe NJ, Koretzky GA. 2000. Adapter proteins in lymphocyte antigen-receptor signaling. Curr Opin Immunol 12(3):256–66.
Nadel S, Newport MJ, Booy R, Levin M. 1996. Variation in the tumor necrosis factor–alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174(4):878–80.
Nash D, Mostashari F, Fine A, Miller J, O’Leary D, Murray K, Huang A, Rosenberg A, Greenberg A, Sherman M, Wong S, Layton M. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344(24):1807–14.
Nasta P, Donisi A, Cattane A, Chiodera A, Casari S. 1997. Acute Histoplasmosis in spelunkers returning from Mato Grosso, Peru. J Travel Med 4(4):176–8.
National Commission on Terrorism. 2000. Countering the Changing Threat of International Terrorism, Report of the Natinal Commission on Terrorism, Pursuant to Public Law 277, 105th Congress, Ambassador L. Paul Bremer III, Chairman.
National Intelligence Council. 2000. National Intelligence Estimate: The Global Infectious Disease Threat and Its Implications for the United States. NIE 99–17D. Washington, DC: NIC.
National Intelligence Council. 2002. The Next Wave of HIV/AIDS: Nigeria, Ethiopia, Russia, India, and China. McLean, VA : Central Intelligence Agency.
National Nosocomial Infections Surveillance System. 2001. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992–June 2001, issued August 2001. Am J Infect Control 29(6):404–21.
National Science and Technology Council (NSTC). 1995. National Science and Technology Council Accomplishments (November 1993–September 1995). [Online] Available: http://www.ostp.gov/NSTC/html/accomp–novsept.html [accessed January 30, 2003].
Navin TR, Juranek DD. 1984. Cryptosporidiosis: clinical, epidemiologic, and parasitologic review. Rev Infect Dis 6(3):313–27.
Nchinda TC. 1998. Malaria: a reemerging disease in Africa. Emerg Infect Dis 4(3):398–403.
NCHS (National Center for Health Statistics). 2001. Health, United States, 2001 with Urban and Rural Health Chartbook. Hyattsville, MD: National Center for Health Statistics.
Nerlich AG, Haas CJ, Zink A, Szeimies U, Hagedorn HG. 1997. Molecular evidence for tuberculosis in an ancient Egyptian mummy. Lancet 350(9088):1404.
Netesov SV, Conrad JL. 2001. Emerging infectious diseases in Russia, 1990–1999. Emerg Infect Dis 7(1):1–5.
Neu HC. 1992. The crisis in antibiotic resistance. Science 257(5073):1064–73.
Neumann G, Kawaoka Y. 2001. Reverse genetics of influenza virus. Virology 287(2):243–50.
Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262(5135):914–7.
Niel C, de Oliveira JM, Ross RS, Gomes SA, Roggendorf M, Viazov S. 1999. High prevalence of TT virus infection in Brazilian blood donors. J Med Virol 57(3):259–63.
NIH (National Institutes of Health). 1999. Annual Report of International Activities. [Online]. Available: http://www.nih.gov/fic/textonly/news/annrpt99.html [accessed January 30, 2003].
NIH. 2001. Human Papillomavirus and Genital Warts Fact Sheet. [Online]. Available: http://www.niaid.nih.gov/factsheets/stdhpv.htm [accessed March 4, 2003].
Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. 1997. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241(1):92–7.
Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354(9172):20–5.
Nohynek H, Eskola J, Laine E, Halonen P, Ruutu P, Saikku P, Kleemola M, Leinonen M. 1991. The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child 145(6):618–22.
NRC (National Research Council). 1983. Manpower Needs and Career Opportunities in the Field Aspects of Vector Biology: Report of a Workshop. Washington, DC: National Academy Press.
NRC. 1999. The Use of Drugs in Food Animals Benefits and Risks. Washington, DC: National Academy Press.
NRC. 2001. Under the Weather: Climate, Ecosystems, and Infectious Disease. Washington, DC: National Academy Press.
O’Brien FG, Pearman JW, Gracey M, Riley TV, Grubb WB. 1999. Community strain of methicillin–resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 37(9):2858–62.
O’Brien TF. 2002. Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin Infect Dis 34 Suppl 3:S78–84.
Ochman H, Moran NA. 2001. Genes lost and genes found: evolution of bacterial pathogenesis and symbiosis. Science 292(5519):1096–9.
Okeke IN, Lamikanra A, Edelman R. 1999. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis 5(1):18–27.
Olliaro P, Cattani J, Wirth D. 1996. Malaria, the submerged disease. JAMA 275(3):230–3.
Olson KB. 1999. Aum Shinrikyo: once and future threat? Emerg Infect Dis 5(4):513–6.
Olson KE, Higgs S, Gaines PJ, Powers AM, Davis BS, Kamrud KI, Carlson JO, Blair CD, Beaty BJ. 1996. Genetically engineered resistance to dengue-2 virus transmission in mosquitoes. Science 272(5263):884–6.
Osterholm MT. 1997. Cyclosporiasis and raspberries—lessons for the future. N Engl J Med 336(22):1597–9.
Osterholm MT, Reves RR, Murph JR, Pickering LK. 1992. Infectious diseases and child day care. Pediatr Infect Dis J 11(8 Suppl):S31–41.
Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, Jacobson LP, Strathdee SA. 2002. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS 16(5): 775–80.
Overby KJ, Kegeles SM. 1994. The impact of AIDS on an urban population of high-risk female minority adolescents: implications for intervention. J Adolesc Health 15(3):216– 27.
Overhage JM, Tierney WM, Zhou XH, McDonald CJ. 1997. A randomized trial of “corollary orders” to prevent errors of omission. J Am Med Inform Assoc 4(5):364–75.
Padula PJ, Edelstein A, Miguel SD, Lopez NM, Rossi CM, Rabinovich RD. 1998. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241(2):323–30.
Pain A, Urban BC, Kai O, Casals–Pascual C, Shafi J, Marsh K, Roberts DJ. 2001. A non– sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357(9267):1502–3.
Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. 2002. Fungal infections among returning travelers. Clin Infect Dis 35(9):1088–95.
Paquet C, van Soest M. 1994. Mortality and malnutrition among Rwandan refugees in Zaire. Lancet 344(8925):823–4.
Parsonnet J. 1998. Helicobacter pylori. Infect Dis Clin North Am 12(1):185–97.
Pater MM, Mittal R, Pater A. 1994. Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends Microbiol 2(7):229–34.
Patz JA, Graczyk TK, Geller N, Vittor AY. 2000. Effects of environmental change on emerging parasitic diseases. Int J Parasitol 30(12–13):1395–405.
Patz JA, McGeehin MA, Bernard SM, Ebi KL, Epstein PR, Grambsch A, Gubler DJ, Reiter P, Romieu I, Rose JB, Samet JM, Trtanj J. 2001. Potential consequences of climate variability and change for human health in the United States. In: Climate Change Impacts on the United States: The Potential Consequences of Climate Variability and Change. Washington, DC: U.S. Global Change Research Program. Cambridge, MA: Cambridge University Press. Pp. 620.
Paul VK, Singh M, Gupta U, Buckshee K, Bhargava VL, Takkar D, Nag VL, Bhan MK, Deorari AK. 1999. Chlamydia trachomatis infection among pregnant women: prevalence and prenatal importance. Natl Med J India 12(1):11–4.
Peeling RW, Brunham RC. 1996. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 2(4):307–19.
Peng MM, Xiao L, Freeman AR, Arrowood MJ, Escalante AA, Weltman AC, Ong CS, Mac Kenzie WR, Lal AA, Beard CB. 1997. Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis 3(4):567–73.
Penman AD, Kohn MA, Fowler M. 1997. A shipboard outbreak of tuberculosis in Mississippi and Louisiana, 1993 to 1994. Am J Public Health 87(7):1234.
Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life–span, and viral generation time. Science 271(5255):1582–6.
Persing DH, Prendergast FG. 1999. Infection, immunity, and cancer. Arch Pathol Lab Med 123(11):1015–22.
Peters CJ, Johnson ED, Jahrling PB, Ksiazek TG, Rollin PE, White J, Hall W, Trotter R, Jaax. 1991. Filoviruses. In: Morse S, ed. Emerging Viruses. New York: Oxford University Press. Pp. 159–75.
Petersen LR, Roehrig JT. 2001. West Nile virus: a reemerging global pathogen. Emerg Infect Dis 7(4):611–4.
PhRMA. 2002. New Medicines in Development for Infectious Diseases. 2002 Survey. Washington, DC: Pharmaceutical Research and Manufacturers of America.
Pickering LK, Evans DG, DuPont HL, Vollet JJ 3rd, Evans DJ Jr. 1981. Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. J Pediatr 99(1): 51–6.
Piot P, Coll Seck AM. 2001. International response to the HIV/AIDS epidemic: planning for success. Bull World Health Org 79(12):1106–12.
Pisani P, Parkin DM, Munoz N, Ferlay J. 1997. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6(6):387–400.
Pisani P, Parkin DM, Bray F, Ferlay J. 1999. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83(1):18–29.
Pittendrigh BR, Gaffney PJ. 2001. Pesticide resistance: can we make it a renewable resource? J Theor Biol 211(4):365–75.
Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. 1999. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 159(8):821–6.
Platonov AE. 2001. West Nile encephalitis in Russia 1999–2001: were we ready? Are we ready? Ann N Y Acad Sci 951:102–16.
Platonov AE, Shipulin GA, Shipulina OY, Tyutyunnik EN, Frolochkina TI, Lanciotti RS, Yazyshina S, Platonova OV, Obukhov IL, Zhukov AN, Vengerov YY, Pokrovskii VI. 2001. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis 7(1):128–32.
Plotkin SA, Mortimer EA, eds. 1994. Vaccines. 2nd ed. Philadelphia: WB Saunders Co.
Polyak CS, Macy JT, Irizarry-De La Cruz M, Lai JE, McAuliffe JF, Popovic T, Pillai SP, Mintz ED. 2002. Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention. Emerg Infect Dis 8(10):1056–9.
Poovorawan Y, Theamboonlers A, Jantaradsamee P, Kaew-in N, Hirsch P, Tangkitvanich P. 1998. Hepatitis TT virus infection in high-risk groups. Infection 26(6):355–8.
Popovic T, Sacchi CT, Reeves MW, Whitney AM, Mayer LW, Noble CA, Ajello GW, Mostashari F, Bendana N, Lingappa J, Hajjeh R, Rosenstein NE. 2000. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis 6(4):428–9.
Potischman N, Brinton LA. 1996. Nutrition and cervical neoplasia. Cancer Causes Control 7(1):113–26.
Prusiner SB. 1995. The prion diseases. Sci Am 272(1):48–51, 54–7.
Qiu H, Jun HW, McCall JW. 1998. Pharmacokinetics, formulation, and safety of insect repellent N,N-diethyl-3-methylbenzamide (deet): a review . J Am Mosq Control Assoc 14(1):12–27.
Ramalingaswami V. 1996. The plague outbreaks of India, 1994—a prologue. Current Science 71:781–806.
Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. 2000. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 283(20):2680–5.
Rappuoli R, Miller HI, Falkow S. 2002. Medicine. The intangible value of vaccination. Science 297(5583):937–9.
Rastogi S, Kapur S, Salhan S, Mittal A. 1999. Chlamydia trachomatis infection in pregnancy: risk factor for an adverse outcome. Br J Biomed Sci 56(2):94–8.
Ray AJ, Hoyen CK, Taub TF, Eckstein EC, Donskey CJ. 2002. Nosocomial transmission of vancomycin-resistant enterococci from surfaces. JAMA 287(11):1400–1.
Raymond M, Chevillon C, Guillemaud T, Lenormand T, Pasteur N. 1998. An overview of the evolution of overproduced esterases in the mosquito Culex pipiens. Philos Trans R Soc Lond B Biol Sci 353(1376):1707–11.
Read RC, Camp NJ, di Giovine FS, Borrow R, Kaczmarski EB, Chaudhary AG, Fox AJ, Duff GW. 2000. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 182(5):1557–60.
Redfield RR, Wright DC, James WD, Jones TS, Brown C, Burke DS. 1987. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 316(11):673–6.
Regis L, Silva-Filha MH, Nielsen-LeRoux C, Charles JF. 2001. Bacteriological larvicides of dipteran disease vectors. Trends Parasitol 17(8):377–80.
Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. 1999. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354(9179):635–9.
Ribera E, Miro JM, Cortes E, Cruceta A, Merce J, Marco F, Planes A, Pare JC, Moreno A, Ocana I, Gatell JM, Pahissa A. 1998. Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 158(18):2043–50.
Rice AL, Sacco L, Hyder A, Black RE. 2000. Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bull World Health Organ 78(10):1207–21.
Richman DD. 2001. HIV chemotherapy. Nature 410(6831):995–1001.
Ritzinger FR. 1965. Disease transmission by aircraft. Aeromed Rev 4:1–10.
Roberts DR, Laughlin LL, Hsheih P, Legters LJ. 1997. DDT, global strategies, and a malaria control crisis in South America. Emerg Infect Dis 3(3):295–302.
Roberts DR, Alecrim WD, Hshieh P, Grieco JP, Bangs M, Andre RG, Chareonviriphap T. 2000. A probability model of vector behavior: effects of DDT repellency, irritancy, and toxicity in malaria control. J Vector Ecol 25(1):48–61.
Roberts L. 2001. Mortality in Eastern Republic of Congo: Results from Eleven Mortality Surveys. [Online]. Available: www.intrescom.org/docs/mortality_2001/mortII_report.pdf [accessed February 8, 2002].
Roivainen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, Eizirik DL, Hovi T, Otonkoski T. 2000. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 85(1):432–40.
Rosebury T. 1947. Experimental Airborne Infection. Baltimore: Williams and Wilkins.
Rousseau JJ. 1993. The Social Contract, 3rd ed. Trans. Henry J. Tozer. London: J.M. Dent.
Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. 1999. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 5(1):9–17.
Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, et al. 1995. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376(6537):246–9.
Saade C, Bateman M, Bendahmane D. The Story of a Successful Public–Private Partnership in Central America: Handwashing for Diarrheal Disease Prevention. 2001. Arlington, VA: Basic Support for Child Survival Project (BASICS II), Environmental Health Project, United Nations Children’s Fund, United States Agency for International Development, World Bank.
Sabato AR, Martin AJ, Marmion BP, Kok TW, Cooper DM. 1984. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child 59(11): 1034–7.
Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2(8618): 983–6.
Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116(4): 273–8.
Sanchez J, Comerford M, Chitwood DD, Fernandez MI, McCoy CB. 2002. High risk sexual behaviours among heroin sniffers who have no history of injection drug use: implications for HIV risk reduction. AIDS Care 14(3):391–8.
Sandia National Laboratories. 2002. Rapid Syndrome Validation Project (RSVP). User’s Manual and Description. DRAFT Version 2.3, 7/21/02. Albuquerque, New Mexico. [Online]. Available: http://rsvp.sandia.gov/ [accessed January 30, 2003].
Sbarbaro J. 2000. Trade Liberalization in Health Insurance: Opportunities and Challenges: The Potential Impact of Introducing or Expanding the Availability of Private Health Insurance Within Low and Middle Income Countries. Commission on Macro Economics and Health. Geneva: WHO.
Schiffman MH, Brinton LA. 1995. The epidemiology of cervical carcinogenesis. Cancer 76(10 Suppl):1888–901.
Schmaljohn C, Hjelle B. 1997. Hantaviruses: a global disease problem. Emerg Infect Dis 3(2):95–104.
Schneider E, Hajjeh RA, Spiegel RA, Jibson RW, Harp EL, Marshall GA, Gunn RA, McNeil MM, Pinner RW, Baron RC, Burger RC, Hutwagner LC, Crump C, Kaufman L, Reef SE, Feldman GM, Pappagianis D, Werner SB. 1997. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 277(11):904–8.
Schoepf BG. 2001. International AIDS research in anthropology: taking a critical perspective on the crisis. Ann Rev Anthropol 30:335–61.
Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342(1):15–20.
Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, Lefkowitz L, Danila R, Stefonek K, Barrett N, Morse D, Pinner R. 2001. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 7(1):92–9.
Schwarcz SK, Kellogg TA, McFarland W, Louie B, Klausner J, Withum DG, Katz MH. 2002. Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis 186(7):1019–22.
Scott TW, Takken W, Knols BG, Boete C. 2002. The ecology of genetically modified mosquitoes. Science 298(5591):117–9.
Sealy DP, Schuman SH. 1983. Endemic giardiasis and day care. Pediatrics 72(2):154–8.
Seas C, Gotuzzo E. 2000. Gram-negative bacilli. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone.
Seggev JS, Lis I, Siman-Tov R, Gutman R, Abu–Samara H, Schey G, Naot Y. 1986. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 57(4):263–5.
Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR. 1994. Maternal vitamin A deficiency and mother-to-child transmission of HIV–1. Lancet 343(8913):1593–7.
Sen A. 1981. Poverty and Famines: An Essay on Entitlement and Deprivation. Oxford and New York: Oxford University Press.
Sen A. 1999. Development as Freedom. New York: Anchor.
Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. 1997. Erythromycin resistance of group A streptococci from throat samples is related to age. Pediatr Infect Dis J 16(7):651–6.
Shah KV. 1997. Human papillomaviruses and anogenital cancers. N Engl J Med 337(19): 1386–8.
Shaman J, Day JF, Stieglitz M. 2002. Drought-induced amplification of Saint Louis encephalitis virus, Florida. Emerg Infect Dis 8(6):575–80.
Shaw DM, Gaerthe B, Leer RJ, Van Der Stap JG, Smittenaar C, Heijne Den Bak–Glashouwer M, Thole JE, Tielen FJ, Pouwels PH, Havenith CE. 2000. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology 100(4):510–8.
Shieh WJ, Guarner J, Layton M, Fine A, Miller J, Nash D, Campbell GL, Roehrig JT, Gubler DJ, Zaki SR. 2000. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis 6(4):370–2.
Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. 2001. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 67(2):561–8.
Sidell FR, Takafuji ET, Franz DR, eds. 1997. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General, United States Army.
Simon PA, Thometz E, Bunch JG, Sorvillo F, Detels R, Kerndt PR. 1999. Prevalence of unprotected sex among men with AIDS in Los Angeles County, California 1995–1997. AIDS 13(8):987–90.
Simor AE, Ofner-Agostini M, Bryce E, Green K, McGeer A, Mulvey M, Paton S. 2001. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance . CMAJ 165(1):21–6.
Simpson VR. 1992. Cryptosporidiosis in newborn red deer (Cervus elaphus). Vet Rec 130(6): 116–8.
Sina BJ, Aultman K. 2001. Resisting resistance. Trends Parasitol 17(7):305–6.
Sinard JH. 2001. Factors affecting autopsy rates, autopsy request rates, and autopsy findings at a large academic medical center. Exp Mol Pathol 70(3):333–43.
Singh N. 2000. Infections in solid organ transplant recipients. Curr Opin Infect Dis 13(4):343– 347.
Smith DL, Harris AD, Johnson JA, Silbergeld EK, Morris JG Jr. 2002. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc Natl Acad Sci U S A 99(9):6434–9.
Smithson AE. 2000. Rethinking the Lessons of Tokyo. In: Smithson AE, Levy LA, eds. Ataxia: The Chemical and Biological Terrorism Threat and the US Response. Stimson Center Report No. 35. Washington, DC: The Henry L. Stimson Center.
Spielman A. 1994. A commentary on research needs for monitoring and containing emergent vector-borne infections. Disease in Evolution: Global Changes and Emergence of Infectious Diseases. Ann NY Acad Sci 740:457–461.
Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979–1987. The Pneumococcal Surveillance Working Group. J Infect Dis 163(6):1273–8.
Srivastava P. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 20:395–425.
Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin–10. Science 289(5483):1352–5.
Stephens DS, Levin B, Halloran ME. 1998. Symposium on population biology, evolution, and control of infectious diseases. Introduction. Am J Med Sci 315(2):63.
Stocker K, Waitzkin H, Iriart C. 1999. The exportation of managed care to Latin America. N Engl J Med 340(14):1131–6.
Strausbaugh LJ. 2001. Emerging health care-associated infections in the geriatric population. Emerg Infect Dis 7(2):268–71.
Stuver SO, Boschi–Pinto C, Trichopoulos D. 1997. Infection with hepatitis B and C viruses, social class and cancer. IARC Sci Publ (138):319–24.
Su X. 2002. Gonococcal resistance to ciprofloxacin and its clinical significance. 12th IUSTI Asia–Pacific Congress on STI, HIV/AIDS. Beijing, 2002. Abstract no. SY103. Pp. 55–56.
Su X, Lind I. 2001. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998. Antimicrob Agents Chemother 45(1):117–23.
Sullivan AD, Wigginton J, Kirschner D. 2001. The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV. Proc Natl Acad Sci U S A 98(18):10214–9.
Summerfield D. 1997. The social, cultural and political dimensions of contemporary war. Med Confl Surviv 13(1):3–25.
Swaminathan B, Barrett TJ, Hunter SB, Tauxe RV. 2001. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis 7(3):382–9.
Swartz MN. 2002. Human diseases caused by foodborne pathogens of animal origin. Clin Infect Dis 34 (Suppl 3):S111–22.
Szucs T. 2000. Cost–benefits of vaccination programmes. Vaccine 18 (Suppl 1):S49–51.
Tabachnick WJ, Wallis GP, Aitken TH, Miller BR, Amato GD, Lorenz L, Powell JR, Beaty BJ. 1985. Oral infection of Aedes aegypti with yellow fever virus: geographic variation and genetic considerations. Am J Trop Med Hyg 34(6):1219–24.
Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, Gray S, Kaczmarski E. 2000. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356(9248):2159.
Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. 2001. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci 356(1416):1829–39.
Taylor LH, Latham SM, Woolhouse ME. 2001a. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356(1411):983–9.
Taylor MT, Belgrader P, Furman BJ, Pourahmadi F, Kovacs GT, Northrup MA. 2001b. Lysing bacterial spores by sonication through a flexible interface in a microfluidic system. Anal Chem 73(3):492–6.
Thiery I, Baldet T, Barbazan P, Becker N, Junginger B, Mas JP, Moulinier C, Nepstad K, Orduz S, Sinegre G. 1997. International indoor and outdoor evaluation of Bacillus sphaericus products: complexity of standardizing outdoor protocols. J Am Mosq Control Assoc 13(3):218–26.
Threlfall EJ, Ward LR, Frost JA, Willshaw GA. 2000. The emergence and spread of antibiotic resistance in food-borne bacteria. Int J Food Microbiol 62(1–2):1–5.
Titus RG, Ribeiro JM. 1988. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239(4845):1306–8.
Tokars JI, Frank M, Alter MJ, Arduino MJ. 2002. National surveillance of dialysis–associated diseases in the United States, 2000. Semin Dial 15(3):162–71.
Toole MJ, Waldman RJ. 1990. Prevention of excess mortality in refugee and displaced populations in developing countries. JAMA 263(24):3296–302.
Toole MJ, Galson S, Brady W. 1993. Are war and public health compatible? Lancet 341(8854):1193–6.
Topcu Z, Chiba I, Fujieda M, Shibata T, Ariyoshi N, Yamazaki H, Sevgican F, Muthumala M, Kobayashi H, Kamataki T. 2002. CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers in Sri Lanka. Carcinogenesis 23(4):595–8.
Topouzis D, du Guerny J. 1999. Sustainable Agriculture/Rural Development and Vulnerability to the AIDS Epidemic. Geneva: UNAIDS/FAO.
Topouzis D, Hemrich G. 2000. Multi-sectoral responses to HIV/AIDS: constraints and opportunities for technical cooperation. J Intern Dev 12:85–99.
Torok TJ, Tauxe RV, Wise RP, Livengood JR, Sokolow R, Mauvais S, Birkness KA, Skeels MR, Horan JM, Foster LR. 1997. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 278(5):389–95.
Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RC, Ferraro MJ. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358(9277):207–8.
Tuazon CU, Sheagren JN. 1974. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 129(6):725–7.
Tzipori S, Angus KW, Campbell I, Sherwood D. 1981. Diarrhea in young red deer associated with infection with Cryptosporidium. J Infect Dis 144(2):170–5.
Umemura T, Alter HJ, Tanaka E, Yeo AE, Shih JW, Orii K, Matsumoto A, Yoshizawa K, Kiyosawa K. 2001. Association between SEN virus infection and hepatitis C in Japan. J Infect Dis 184(10):1246–51.
UNAIDS. 2000. Report on the Global HIV/AIDS Epidemic: June 2000. UNAIDS/00.13E. Geneva: Joint United Nations Programme on HIV/AIDS.
UNAIDS. 2001. Twenty years of HIV/AIDS in graphics. [Online]. Available: http://www.unaids.org/fact_sheets/files/AIDStwenty_en.html#graphics [accessed March 4, 2003].
UNAIDS. 2002. Report on the Global HIV/AIDS Epidemic: July 2002. UNAIDS/02.26E. Geneva: Joint United Nations Programme on HIV/AIDS.
UNAIDS, WHO. 2001. AIDS Epidemic Update: December 2001. UNAIDS/01.74E—WHO/ CDS/NCS/2001.2. Geneva: Joint United Nations Programme on HIV/AIDS/World Health Organization.
UNAIDS, WHO. 2002. AIDS epidemic update. UNAIDS/02.46E. Geneva Switzerland: World Health Organization.
Union of Concerned Scientists (UCS). 2002. Food and Environment: Antibiotic Resistance. http://www.ucsusa.org/food_and_environment/antibiotic_resistance/index.cfm?pageID=10.
United Nations Economic Commission for Africa. 2000. African Development Forum 2000, AIDS: the Greatest Leadership Challenge HIV/AIDS and Economic Development in Sub– Saharan Africa. United Nations Economic Commission for Africa. [Online]. Available: http://www.uneca.org/adf2000/theme1.htm#1 [accessed March 5, 2003].
United Nations Popuation Division. 1999. The World at Six Billion. ESA/P/WP.154. New York: Population Division, Department of Economic and Social Affairs.
United Nations Population Division. 2001. World Population Prospects: The 2000 Revision. ESA/P/WP.165. New York: United Nations.
United Nations Population Division. 2002. World Urbanization Prospects: The 2001 Revision. ESA/P/WP.173. New York: Population Division, Department of Economic and Social Affairs.
United Nations Population Fund (UNFPA). 1999. The State of World Population 1999. [Online]. Available: http://www.unfpa.org/swp/1999/contents.htm [accessed February 14, 2003].
UNFPA. 2001. The State of World Population 2001. [Online]. Available: http://www.unfpa.org/swp/swpmain.htm [accessed February 14, 2003].
United States Commission on National Security/21st Century. 2001. Road Map for National Security: Imperative for Change. The Phase III Report of the U.S. Commission on National Security/21st Century.
University Renal Research and Education Association, United Network for Organ Sharing. 2003. 2002 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1992–2001. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation.
Uppal PK. 2000. Emergence of Nipah virus in Malaysia. Ann N Y Acad Sci 916:354–7.
U.S. Census Bureau. 2001. Population Profile of the United States: 2000 (Internet Release). [Online]. Available: http://www.census.gov/population/www/pop–profile/profile2000.html [accessed March 5, 2003].
U.S. Census Bureau. 2002a. United States Census 2000. [Online]. Available: http://www.census.gov/main/www/cen2000.html [accessed February 14, 2003].
U.S. Census Bureau. 2002b. Current Population Reports, P60–219, Poverty in the United States: 2001. Washington, DC: U.S. Government Printing Office.
U.S. Congress, Office of Technology Assessment. 1993a. Technologies Underlying Weapons of Mass Destruction, OTA–BP–ISC–115. Washington, DC: U.S. Government Printing Office.
U.S. Congress, Office of Technology Assessment. 1993b. Proliferation of Weapons of Mass Destruction: Assessing the Risks, OTA–ISC–559. Washington, DC: U.S. Government Printing Office.
USDA. 1997. Part III: Changes in the U.S. Pork Industry 1990–1995 Fort Collins, CO: U.S. Department of Agriculture.
USDA. 2000a. Changes in the U.S. Feedlot Industry, 1994–1999. #N327.0800. Fort Collins, CO: USDA:APHIS:VS, CEAH, National Animal Health Monitoring System.
USDA. 2000b. Part III: Health Management and Biosecurity in U.S. Feedlots, 1999. #N336.1200. Fort Collins, CO: USDA:APHIS:VS, CEAH, National Animal Health Monitoring System .
USDA. 2001. Part I: Reference of Swine Health and Management in the United States, 2000, National Health Monitoring System. #N338.0801. Fort Collins, CO: U.S. Department of Agriculture.
USDA, EPA. 1999. Unified National Strategy for Animal Feeding Operations. Washington, DC: U.S. Department of Agriculture, Environmental Protection Agency.
Usera MA, Aladuena A, Gonzalez R, De la Fuente M, Garcia–Pena J, Frias N, Echeita MA. 2002. Antibiotic resistance of Salmonella spp. from animal sources in Spain in 1996 and 2000. J Food Prot 65(5):768–73.
Valencia GB, Banzon F, Cummings M, McCormack WM, Glass L, Hammerschlag MR. 1993. Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection. Pediatr Infect Dis J 12(7):571–3.
Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, Sacks DL, Ribeiro JM. 2001. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med 194(3):331–42.
van Belkum A, Verbrugh H. 2001. 40 years of methicillin resistant Staphylococcus aureus. BMJ 323(7314):644–5.
Venczel LV, Desai MM, Vertz PD, England B, Hutin YJ, Shapiro CN, Bell BP. 2001. The role of child care in a community-wide outbreak of hepatitis A. Pediatrics 108(5):E78.
Vicca AF. 1999. Nursing staff workload as a determinant of methicillin–resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 43(2):109–13.
Vitek CR, Wharton M. 1998. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis 4(4):539–50.
Volmink J, Garner P. 2001. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev (4):CD003343.
Volmink J, Matchaba P, Garner P. 2000. Directly observed therapy and treatment adherence. Lancet 355(9212):1345–50.
Walker JB, Hussey EK, Treanor JJ, Montalvo A Jr, Hayden FG. 1997. Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza. J Infect Dis 176(6):1417–22.
Wallensteen P, Sollenberg M. 1999. Armed conflict, 1989–1998. J Peace Res 36(5):593–606.
Wallensteen P, Sollenberg M. 2001. Armed conflict, 1989–2000. J Peace Res 38(5):629–644.
Weatherall DJ. 1996a. The genetics of common diseases: the implications of population variability. Ciba Found Symp 197:300–8; discussion 308–11.
Weatherall DJ. 1996b. Host genetics and infectious disease. Parasitology 112 Suppl:S23–9.
Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56(1):152–79.
Wegener HC, Aarestrup FM, Jensen LB, Hammerum AM, Bager F. 1999. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 5(3):329–35.
Wellems TE, Plowe CV. 2001. Chloroquine-resistant malaria. J Infect Dis 184(6):770–6.
Wenzel RP, Edmond MB. 2001. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 7(2):174–7.
Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. 1991. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 91(3B): 221S–227S.
West CE. 2000. Vitamin A and measles. Nutr Rev 58(2 Pt 2):S46–54.
Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP, Vandenbroucke JP. 1997. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349(9046):170–3.
White DG, Zhao S, Sudler R, Ayers S, Friedman S, Chen S, McDermott PF, McDermott S, Wagner DD, Meng J. 2001. The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med 345(16):1147–54.
Whitehead Institute. 2002. Whitehead—Who We Are. [Online]. Available: www.wi.mit.edu/who/who.html [accessed February 10, 2003].
Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Lefkowitz L, Cieslak PR, Cetron M, Zell ER, Jorgensen JH, Schuchat A. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343(26):1917–24.
WHO. 1970. Health Aspects of Chemical and Biological Weapons. Geneva: World Health Organization.
WHO. 1996. Fighting Disease, Fostering Development. The World Health Report 1996. Geneva: World Health Organization.
WHO. 1997. Vitamin A Supplements: A Guide to Their Use in the Treatment of Vitamin A Deficiency and Xerophthalmia. Geneva: World Health Organization.
WHO. 1998a. World Health Report 1998: Life in the 21st Century: A Vision for All. Geneva: World Health Organization.
WHO. 1998b. Fact Sheets: Global Infectious Disease Surveillance. Fact Sheet No 200. Geneva: WHO.
WHO. 1999a. Removing Obstacles to Healthy Development. Report on Infectious Disease. Geneva: WHO.
WHO. 1999b. World Health Report 1999: Making a Difference. Geneva: World Health Organization.
WHO. 1999c. Food Safety Issues Associated with Products from Aquaculture. Geneva: World Health Organization.
WHO. 1999d. What Is DOTS? A Guide to Understanding the WHO-Recommended TB Control Strategy Known as DOTS. WHO/CDS/CPC/TB/99.270. Geneva: World Health Organization.
WHO. 1999e. Influenza Pandemic Preparedness Plan. The Role of WHO and Guidelines for National and Regional Planning. Geneva: World Health Organization.
WHO. 2000a. World Health Report 2000: Health Systems: Improving Performance. Geneva: World Health Organization.
WHO. 2000b. Infant and young child nutrition, Report by the Director-General. Fifty-third World Health Assembly. A53/7.
WHO. 2000c. Outbreak news: Rift Valley fever, Saudi Arabia, August–October 2000. Weekly Epidemiological Record 75(46):369–376.
WHO. 2000d. Cholera Factsheet. Fact Sheet No 107. Geneva: World Health Organization.
WHO. 2000e. Fifty-Third World Health Assembly. Stop Tuberculosis Initiative, Report by the Director General. A53/5. Geneva: World Health Organization.
WHO. 2000f. WHO Global Principles for the Containment of Antimicrobial Resistance in Animals Intended for Food. Report of a WHO consultation with the participation of the Food and Agriculture Organization of the United Nations and the Office International des Epizooties. Geneva, 5–9 June 2000. WHO/CDS/CSR/APH/2000.4.
WHO. 2000g. A major killer in west and central Africa. Measles Bulletin. Issue 5. WHO/ V&B/00.38.
WHO. 2001a. World Health Report 2001: Global Tuberculosis Control. Geneva: World Health Organization.
WHO. 2001b. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva: World Health Organization.
WHO. 2001c. Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health. Geneva: World Health Organization.
WHO. 2001d. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections, Overview and Estimates. WHO/HIV_AIDS/2001.02. Geneva: World Health Organization.
WHO. 2001e. Nipah Virus Factsheet. Fact Sheet No 262. [Online]. Available: http://www.who.int/inf–fs/en/fact262.html [accessed February 21, 2003].
WHO. 2001f. Cholera, 2000. Wkly Epidemiol Rec 76(31):233–40.
WHO. 2001g. WHO Vaccine-Preventable Diseases: Monitoring System. 2001 Global Summary. Department of Vaccines and Biologicals. WHO/V&B/01.34. Geneva: World Health Organization.
WHO. 2001h. WHO and Lyon—A Partnership for Global Health Security. [Online]. Available: http://www.who.int/emc/lyon/ [accessed January30, 2003].
WHO. 2001i. WHO Global Strategy for Containment of Antimicrobial Resistance. WHO/ CDS/CSR/DRS/2001.2a. Geneva: World Health Organization.
WHO. 2002a. Coordinates 2002—Charting progress against AIDS, TB and malaria. [Online]. Available: http://www.who.int/infectious-disease-news/ [accessed February 13, 2003].
WHO. 2002b. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization.
WHO. 2002c. Tuberculosis. [Online]. Available: http://www.who.int/mediacentre/factsheets/who104/en/index.html [accessed February 21, 2003].
WHO. 2002d. Nutrition. [Online]. Available: http://www.who.int/nut/ [accessed February 20, 2003].
WHO. 2002e. Use of Antimicrobials Outside Human Medicine and Resultant Antimicrobial Resistance in Humans. Fact Sheet 268. Geneva: WHO.
WHO. 2002f. Prevention of Hospital-Acquired Infections, A Practical Guide. Geneva: World Health Organization.
WHO. 2002g. An Expanded DOTS Framework for Effective Tuberculosis Control. WHO/ CDS/TB/2002.297. Geneva: World Health Organization.
WHO. 2002h. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2002. WHO/CDS/TB/2002.295. Geneva: World Health Organization.
WHO. 2002i. Tuberculosis. Fact Sheet No 104. [Online]. Available: http://www.who.int/mediacentre/factsheets/who104/en/index.html [accessed February 6, 2003].
WHO. 2002j. Scaling up the Response to Infectious Diseases: A Way Out of Poverty. WHO/ CDS/2002.7. Geneva: World Health Organization.
WHO. 2002k. Global measles mortality reduction and regional elimination, 2000–2001. Part II. Wkly Epidemiol Rec 77(8):58–61.
WHO. 2003a. TDR Home Page. [Online]. Available: www.who.int/tdr [accessed February 28, 2003].
WHO. 2003b. Communicable Disease Surveillance & Response (CSR): Global Outbreak Alert & Response Network. [Online]. Available: http://www.who.int/csr/outbreaknetwork/en/ [accessed January 30, 2003].
WHO, UNICEF. 2001. WHO–UNICEF Joint Statement on Strategies to Reduce Measles Mortality Worldwide. Geneva: WHO.
Wick RL Jr, Irvine LA. 1995. The microbiological composition of airliner cabin air. Aviat Space Environ Med 66(3):220–4.
Wierup M. 2001. The Swedish experience of the 1986 year ban of antimicrobial growth promoters, with special reference to animal health, disease prevention, productivity, and usage of antimicrobials. Microb Drug Resist 7(2):183–90.
Wierzba TF, El–Yazeed RA, Savarino SJ, Mourad AS, Rao M, Baddour M, El–Deen AN, Naficy AB, Clemens JD. 2001. The interrelationship of malnutrition and diarrhea in a periurban area outside Alexandria, Egypt. J Pediatr Gastroenterol Nutr 32(2):189–96.
Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. 1996. A new variant of Creutzfeldt–Jakob disease in the UK. Lancet 347(9006):921–5.
Willadsen P. 2001. The molecular revolution in the development of vaccines against ectoparasites. Vet Parasitol 101(3–4):353–68.
Willadsen PL, Billingsley PF. 1996. Immune intervention against blood-feeding insects. In: Lehane ML, Billinsley PF, eds. Biology of the Insect Midgut. London: Chapman and Hall. Pp. 323–340.
Wilson ME. 1995. Travel and the emergence of infectious diseases. Emerg Infect Dis 1(2):39– 46.
Wilson ML. 1994. Rift Valley fever virus ecology and the epidemiology of disease emergence. Ann N Y Acad Sci 740:169–80.
Wilson ML. 2001. Ecology and infectious disease. In: Aron JL, Patz J, eds. Ecosystem Change and Public Health: A Global Perspective. Baltimore: Johns Hopkins University Press.
Wolitski RJ, Valdiserri RO, Denning PH, Levine WC. 2001. Are we headed for a resurgence of the HIV epidemic among men who have sex with men? Am J Pub Health 91(6):883–8.
Wong D, Nye K, Hollis P. 1991. Microbial flora on doctors’ white coats. BMJ 303(6817): 1602–4.
Wood R, Maartens G, Lombard CJ. 2000. Risk factors for developing tuberculosis in HIV–1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 23(1):75–80.
World Bank. 2001. World Development Report: Attacking Poverty 2000/2001. New York: Oxford University Press.
World Bank. 2002. World Development Indicators 2001. Washington, DC: World Bank.
World Bank Group. 2002. Poverty Trends and Voices of the Poor: Income Poverty. [Online]. Available: www.worldbank.org/poverty/data/trends/income.htm [accessed February 27, 2003].
World Resources Institute, United Nations Environment Programme, United Nations Development Programme, World Bank. 1996. World Resources 1996–97. New York and Oxford: Oxford University Press.
World Tourism Organization. 2002. Tourism Highlights 2002. Madrid, Spain: World Tourism Organization.
Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa–associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342(8871):575–7.
Wright PF, Webster RG. 2001. Orthomyxoviruses. In: Knipe DM, Howley PM, eds. Fields Virology, 4th ed. Philadelphia: Lippincott Williams & Wilkins. Pp. 1533–79.
Yang S. 1998. FoodNet and Enter-net: emerging surveillance programs for foodborne diseases. Emerg Infect Dis 4(3):457–8.
Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. 1994. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 149(5):1348–53.
Yates T, Mills J, Parmenter C, Ksiazek T, Parmenter R, Calisher C, Nichol S, Abbott K, Young J, Morrison M, Beaty B, Dunnum J, Baker RJ, Peters CJ. 2002a. The ecology and evolutionary history of an emergent disease: hantavirus pulmonry syndrome. Bioscience 52(11):989–98.
Yates T, Mills J, Parmenter C, Ksiazek T, Parmenter R, Calisher C, Nichol S, Abbott K, Young J, Morrison M, Beaty B, Dunnum J, Baker RJ, Peters CJ. 2002b. Biocomplexity and hantavirus pulmonary syndrome: the ecology of an outbreak. Bioscience. Submitted.
Ylitalo N, Josefsson A, Melbye M, Sorensen P, Frisch M, Andersen PK, Sparen P, Gustafsson M, Magnusson P, Ponten J, Gyllensten U, Adami HO. 2000. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 60(21):6027–32.
Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, van der Linden HC, Runsink AP, de Schipper FA, Meijer CJ. 2001. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears . Br J Cancer 85(3):398–404.